| Ident. | Authors (with country if any) | Title |
|---|
| 000019 |
Thomas Mcdonnell [Royaume-Uni] ; Chris Wincup [Royaume-Uni] ; Ina Buchholz [Allemagne] ; Charis Pericleous [Royaume-Uni] ; Ian Giles [Royaume-Uni] ; Vera Ripoll [Royaume-Uni] ; Hannah Cohen [Royaume-Uni] ; Mihaela Delcea [Allemagne] ; Anisur Rahman [Royaume-Uni] | The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS |
| 000071 |
Dale Fisher [Singapour] ; David Heymann [Royaume-Uni] | Q&A: The novel coronavirus outbreak causing COVID-19 |
| 000106 |
Dargham B. M. Hammad [Royaume-Uni] ; S. L. Hider [Royaume-Uni] ; Veranja C. Liyanapathirana [Sri Lanka] ; Daniel P. Tonge [Royaume-Uni] | Molecular Characterization of Circulating Microbiome Signatures in Rheumatoid Arthritis |
| 000118 |
Evdokia Michalopoulou [Royaume-Uni] ; Francesca R. Auciello [Royaume-Uni] ; Vinay Bulusu [Royaume-Uni] ; David Strachan [Royaume-Uni] ; Andrew D. Campbell [Royaume-Uni] ; Jacqueline Tait-Mulder [Royaume-Uni] ; Saadia A. Karim [Royaume-Uni] ; Jennifer P. Morton [Royaume-Uni] ; Owen J. Sansom [Royaume-Uni] ; Jurre J. Kamphorst [Royaume-Uni] | Macropinocytosis Renders a Subset of Pancreatic Tumor Cells Resistant to mTOR Inhibition |
| 000142 |
Leo Swadling [Royaume-Uni] ; Laura J. Pallett [Royaume-Uni] ; Mariana O. Diniz [Royaume-Uni] ; Josephine M. Baker [Royaume-Uni] ; Oliver E. Amin [Royaume-Uni] ; Kerstin A. Stegmann [Royaume-Uni] ; Alice R. Burton [Royaume-Uni] ; Nathalie M. Schmidt [Royaume-Uni] ; Anna Jeffery-Smith [Royaume-Uni] ; Nekisa Zakeri [Royaume-Uni] ; Kornelija Suveizdyte [Royaume-Uni] ; Farid Froghi [Royaume-Uni] ; Giuseppe Fusai [Royaume-Uni] ; William M. Rosenberg [Royaume-Uni] ; Brian R. Davidson [Royaume-Uni] ; Anna Schurich [Royaume-Uni] ; A. Katharina Simon [Royaume-Uni] ; Mala K. Maini [Royaume-Uni] | Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence |
| 000147 |
Bo Li [États-Unis] ; Sara M. Clohisey ; Bing Shao Chia [États-Unis] ; Bo Wang ; Ang Cui [États-Unis] ; Thomas Eisenhaure [États-Unis] ; Lawrence D. Schweitzer [États-Unis] ; Paul Hoover [États-Unis] ; Nicholas J. Parkinson ; Aharon Nachshon [Israël] ; Nikki Smith ; Tim Regan ; David Farr ; Michael U. Gutmann ; Syed Irfan Bukhari [États-Unis] ; Andrew Law ; Maya Sangesland [États-Unis] ; Irit Gat-Viks [États-Unis, Israël] ; Paul Digard ; Shobha Vasudevan [États-Unis] ; Daniel Lingwood [États-Unis] ; David H. Dockrell [Royaume-Uni] ; John G. Doench [États-Unis] ; J. Kenneth Baillie ; Nir Hacohen [États-Unis] | Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection |
| 000178 |
Didier Raoult [France] ; Alimuddin Zumla [Royaume-Uni] ; Franco Locatelli [Italie] ; Giuseppe Ippolito [Italie] ; Guido Kroemer [France] | Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses |
| 000197 |
Antoine Dewitte [France] ; Julien Villeneuve [Royaume-Uni] ; Sébastien Lepreux [France] ; Marion Bouchecareilh [France] ; Xavier Gauthereau [France] ; Claire Rigothier [France] ; Christian Combe [France] ; Alexandre Ouattara [France] ; Jean Ripoche [France] | CD154 Induces Interleukin-6 Secretion by Kidney Tubular Epithelial Cells under Hypoxic Conditions: Inhibition by Chloroquine |
| 000224 |
Alaa Riezk [Royaume-Uni] ; John G. Raynes [Royaume-Uni] ; Vanessa Yardley [Royaume-Uni] ; Sudaxshina Murdan [Royaume-Uni] ; Simon L. Croft [Royaume-Uni] | Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicanaIn Vitro |
| 000254 |
Philippa M. Wells [Royaume-Uni] ; Frances M. K. Williams [Royaume-Uni] ; M. L. Matey-Hernandez [Royaume-Uni] ; Cristina Menni [Royaume-Uni] ; Claire J. Steves [Royaume-Uni] | ‘RA and the microbiome: do host genetic factors provide the link? |
| 000285 |
Eve M. D. Smith [Royaume-Uni] ; Hanna Lythgoe [Royaume-Uni] ; Christian M. Hedrich [Royaume-Uni] | Vasculitis in Juvenile-Onset Systemic Lupus Erythematosus |
| 000289 |
Guanghui Liu [Suède] ; Catherine Betts [Royaume-Uni] ; Danen M. Cunoosamy [Suède, États-Unis] ; Per M. Berg [Suède] ; Jorrit J. Hornberg [Suède] ; Kinga Balogh Sivars [Suède] ; Taylor S. Cohen [États-Unis] | Use of precision cut lung slices as a translational model for the study of lung biology |
| 000344 |
Cindy S. Chu [Thaïlande, Royaume-Uni] ; Germana Bancone [Thaïlande, Royaume-Uni] ; Nay Lin Soe [Thaïlande] ; Verena I. Carrara [Thaïlande, Suisse] ; Gornpan Gornsawun [Thaïlande] ; François Nosten [Thaïlande, Royaume-Uni] | The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis |
| 000345 |
Paraskevi Dimou [Royaume-Uni] ; Rachael D. Wright [Royaume-Uni] ; Kelly L. Budge [Royaume-Uni] ; Angela Midgley [Royaume-Uni] ; Simon C. Satchell [Royaume-Uni] ; Matthew Peak [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] | The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis |
| 000379 |
Michela Mazzon [Royaume-Uni] ; Mark Marsh [Royaume-Uni] | Targeting viral entry as a strategy for broad-spectrum antivirals |
| 000391 |
Mercedes Segovia [Uruguay] ; Sofia Russo [Uruguay] ; Mathias Jeldres [Uruguay] ; Yamil D. Mahmoud [Argentine] ; Valentina Perez [Uruguay] ; Maite Duhalde [Uruguay] ; Pierre Charnet [France] ; Matthieu Rousset [France] ; Sabina Victoria [Uruguay] ; Florencia Veigas [Argentine] ; Cédric Louvet [France] ; Bernard Vanhove [France] ; R. Andrés Floto [Royaume-Uni] ; Ignacio Anegon [France] ; Maria Cristina Cuturi [France] ; M. Romina Girotti [Argentine] ; Gabriel A. Rabinovich [Argentine] ; Marcelo Hill [Uruguay] | Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation |
| 000404 |
Paramita Baruah [Royaume-Uni] ; Jessica Bullenkamp [Royaume-Uni] ; Philip O. G. Wilson [Royaume-Uni] ; Michael Lee [Royaume-Uni] ; Juan Carlos Kaski [Royaume-Uni] ; Ingrid E. Dumitriu [Royaume-Uni] | TLR9 Mediated Tumor-Stroma Interactions in Human Papilloma Virus (HPV)-Positive Head and Neck Squamous Cell Carcinoma Up-Regulate PD-L1 and PD-L2 |
| 000468 |
Jennifer Bryant [Royaume-Uni] ; Nikolaos Batis [Royaume-Uni] ; Anna Clara Franke [Royaume-Uni] ; Gabriella Clancey [Royaume-Uni] ; Margaret Hartley [Royaume-Uni] ; Gordon Ryan [Royaume-Uni] ; Jill Brooks [Royaume-Uni] ; Andrew D. Southam [Royaume-Uni] ; Nicholas Barnes [Royaume-Uni] ; Joanna Parish [Royaume-Uni] ; Sally Roberts [Royaume-Uni] ; Farhat Khanim [Royaume-Uni] ; Rachel Spruce [Royaume-Uni] ; Hisham Mehanna [Royaume-Uni] | Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma |
| 000469 |
Marina Bacci [Italie] ; Nicla Lorito [Italie] ; Luigi Ippolito [Italie] ; Matteo Ramazzotti [Italie] ; Simone Luti [Italie] ; Simone Romagnoli [Italie] ; Matteo Parri [Italie] ; Francesca Bianchini [Italie] ; Federica Cappellesso [Belgique] ; Federico Virga [Belgique, Italie] ; Qiong Gao [Royaume-Uni] ; Bruno M. Sim Es [Royaume-Uni] ; Elisabetta Marangoni [France] ; Lesley-Ann Martin [Royaume-Uni] ; Giuseppina Comito [Italie] ; Manuela Ferracin [Italie] ; Elisa Giannoni [Italie] ; Massimiliano Mazzone [Belgique] ; Paola Chiarugi [Italie] ; Andrea Morandi [Italie] | Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer |
| 000471 |
Ahmed Tawfik [Irlande (pays)] ; Paul Knight [Royaume-Uni] ; Carrie A. Duckworth ; D. Mark Pritchard ; Jonathan M. Rhodes ; Barry J. Campbell | Replication of Crohn’s Disease Mucosal E. coli Isolates inside Macrophages Correlates with Resistance to Superoxide and Is Dependent on Macrophage NF-kappa B Activation |
| 000541 |
Gisele Bulh Es Portapilla [Brésil] ; Luiz Miguel Pereira [Brésil] ; Cássia Mariana Bronzon Da Costa [Brésil] ; Maiara Voltarelli Providello [Brésil] ; Pedro Alexandre Sampaio Oliveira [Brésil] ; Amanda Goulart [Brésil] ; Naira Ferreira Anchieta [Brésil] ; Mark Wainwright [Royaume-Uni] ; Gilberto Bida Leite Braga [Brésil] ; Sérgio De Albuquerque [Brésil] | Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro |
| 000545 |
Denis Choquette [Canada] ; Louis Bessette [Canada] ; Evo Alemao [États-Unis] ; Boulos Haraoui [Canada] ; Roelien Postema [Royaume-Uni] ; Jean-Pierre Raynauld [Canada] ; Louis Coupal [Canada] | Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry |
| 000550 |
Abigail R. Tirrell [États-Unis] ; Katelyn M. Vendrely [États-Unis] ; Lisa A. Checkley [États-Unis] ; Sage Z. Davis [États-Unis] ; Marina Mcdew-White [États-Unis] ; Ian H. Cheeseman [États-Unis] ; Ashley M. Vaughan [États-Unis] ; François H. Nosten [Thaïlande, Royaume-Uni] ; Timothy J. C. Anderson [États-Unis] ; Michael T. Ferdig [États-Unis] | Pairwise growth competitions identify relative fitness relationships among artemisinin resistant Plasmodium falciparum field isolates |
| 000577 |
Martin Michaelis [Royaume-Uni] ; Malte C. Kleinschmidt [Allemagne] ; Denisa Bojkova [Allemagne] ; Holger F. Rabenau [Allemagne] ; Mark N. Wass [Royaume-Uni] ; Jindrich Cinatl Jr. [Allemagne] | Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2 |
| 000656 |
Toby M. Maher [Royaume-Uni] ; Wim Wuyts [Belgique] | Management of Fibrosing Interstitial Lung Diseases |
| 000695 |
Valentina Pucino [Royaume-Uni] ; Michelangelo Certo [Royaume-Uni] ; Vinay Bulusu [Royaume-Uni] ; Danilo Cucchi [Royaume-Uni] ; Katriona Goldmann [Royaume-Uni] ; Elena Pontarini [Royaume-Uni] ; Robert Haas [Royaume-Uni] ; Joanne Smith [Royaume-Uni] ; Sarah E. Headland [Royaume-Uni] ; Kevin Blighe [Royaume-Uni] ; Massimiliano Ruscica [Italie] ; Frances Humby [Royaume-Uni] ; Myles J. Lewis [Royaume-Uni] ; Jurre J. Kamphorst [Royaume-Uni] ; Michele Bombardieri [Royaume-Uni] ; Costantino Pitzalis [Royaume-Uni] ; Claudio Mauro [Royaume-Uni] | Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4+ T Cell Metabolic Rewiring |
| 000709 |
Patrick Kiely [Royaume-Uni] ; A D Busby [Royaume-Uni] ; E. Nikiphorou [Royaume-Uni] ; K. Sullivan [Royaume-Uni] ; D A Walsh [Royaume-Uni] ; P. Creamer [Royaume-Uni] ; J. Dixey [Royaume-Uni] ; A. Young [Royaume-Uni] | Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts |
| 000748 |
Beth I. Wallace [États-Unis] ; Chelsea A. Harris ; Lu Wang ; Mochuan Liu ; Jung-Sheng Chen ; Chang-Fu Kuo [Royaume-Uni] ; Kevin C. Chung | Impact of Cumulative Corticosteroid Dosage on Preventable Hospitalization among Taiwanese Patients with Ankylosing Spondylitis and Inflammatory Bowel Disease |
| 000749 |
M. J. Cuadrado [Royaume-Uni] ; I. Calatayud [Royaume-Uni] ; M. Urquizu-Padilla [Royaume-Uni] ; S. Wijetilleka [Royaume-Uni] ; S. Kiani-Alikhan [Royaume-Uni] ; M. Y. Karim [Qatar] | Immunoglobulin abnormalities are frequent in patients with lupus nephritis |
| 000759 |
Rebecca Carter [Royaume-Uni] ; Azadeh Cheraghchi-Bashi [Royaume-Uni] ; Adam Westhorpe [Royaume-Uni] ; Sheng Yu [Royaume-Uni] ; Yasmin Shanneik [Royaume-Uni] ; Elena Seraia [Royaume-Uni] ; Djamila Ouaret [Royaume-Uni] ; Yasuhiro Inoue [Japon] ; Catherine Koch [États-Unis] ; Jenny Wilding [Royaume-Uni] ; Daniel Ebner [Royaume-Uni] ; Anderson J. Ryan [Royaume-Uni] ; Francesca M. Buffa [Royaume-Uni] ; Ricky A. Sharma [Royaume-Uni] | Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
|
| 000774 |
Peter. C. Taylor [Royaume-Uni] ; Alejandro Balsa Criado ; Anne-Barbara Mongey ; Jerome Avouac ; Hubert Marotte ; Rudiger B. Mueller | How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy |
| 000784 |
Nipun Lakshitha De Silva [Sri Lanka] ; Suranjith L. Seneviratne [Sri Lanka, Royaume-Uni] | Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review |
| 000786 |
David Kuo [États-Unis] ; Jennifer Ding [États-Unis] ; Ian S. Cohn [États-Unis] ; Fan Zhang [États-Unis] ; Kevin Wei [États-Unis] ; Deepak A. Rao [États-Unis] ; Cristina Rozo [États-Unis] ; Upneet K. Sokhi [États-Unis] ; Sara Shanaj [États-Unis] ; David J. Oliver [États-Unis] ; Adriana P. Echeverria [États-Unis] ; Edward F. Dicarlo [États-Unis] ; Michael B. Brenner [États-Unis] ; Vivian P. Bykerk [États-Unis] ; Susan M. Goodman [États-Unis] ; Soumya Raychaudhuri [États-Unis, Royaume-Uni] ; Gunnar R Tsch [Suisse, États-Unis] ; Lionel B. Ivashkiv [États-Unis] ; Laura T. Donlin [États-Unis] | HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness |
| 000852 |
Peter C. Taylor ; Didier Saurigny [Royaume-Uni] ; Jiri Vencovsky [République tchèque] ; Tsutomu Takeuchi [Japon] ; Tadashi Nakamura [Japon] ; Galina Matsievskaia [Russie] ; Barbara Hunt [États-Unis] ; Thomas Wagner [Suisse] ; Bernard Souberbielle [Royaume-Uni] | Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial |
| 000856 |
Davide Schiroli [Royaume-Uni] ; María J. G Mara [Espagne] ; Eleonora Maurizi [Royaume-Uni] ; Sarah D. Atkinson [Royaume-Uni] ; Laura Mairs [Royaume-Uni] ; Kathleen A. Christie [Royaume-Uni] ; Diego F. Cobice [Royaume-Uni] ; Cian M. Mccrudden [Royaume-Uni] ; M. Andrew Nesbit [Royaume-Uni] ; Isabel Haro [Espagne] ; Tara Moore [Royaume-Uni] | Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide |
| 000868 |
Katja B. Kostelnik [Royaume-Uni] ; Amy Barker [Royaume-Uni] ; Christopher Schultz [Royaume-Uni] ; Tom P. Mitchell [Royaume-Uni] ; Vinothini Rajeeve [Royaume-Uni] ; Ian J. White [Royaume-Uni] ; Michel Aurrand-Lions [France] ; Sussan Nourshargh [Royaume-Uni] ; Pedro Cutillas [Royaume-Uni] ; Thomas D. Nightingale [Royaume-Uni] | Dynamic trafficking and turnover of JAM-C is essential for endothelial cell migration |
| 000884 |
Anna Stainer [Royaume-Uni] ; Alex Rice [Royaume-Uni] ; Anand Devaraj [Royaume-Uni] ; Joseph Luke Barnett [Royaume-Uni] ; Jacqueline Donovan [Royaume-Uni] ; Maria Kokosi [Royaume-Uni] ; Andrew Gordon Nicholson [Royaume-Uni] ; Tom Cairns [Royaume-Uni] ; Athol Umfrey Wells [Royaume-Uni] ; Elisabetta Augusta Renzoni [Royaume-Uni] | Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults |
| 000907 |
Mariam Al-Attar [Royaume-Uni] ; Maria De Santis [Italie] ; Marco Massarotti [Royaume-Uni] | DRESS syndrome in response to Denosumab: First documented case report |
| 000939 |
Nina Kaludercic [Italie] ; Maria Chiara Maiuri [France] ; Susmita Kaushik [États-Unis] ; Álvaro F. Fernández [États-Unis] ; Jenny De Bruijn [Allemagne] ; Francesca Castoldi [France] ; Yun Chen [États-Unis] ; Jumpei Ito [Royaume-Uni] ; Risa Mukai [États-Unis] ; Tomokazu Murakawa [Royaume-Uni] ; Jihoon Nah [États-Unis] ; Federico Pietrocola [Espagne] ; Toshiro Saito [Japon] ; Salwa Sebti [États-Unis] ; Martina Semenzato [Italie] ; Lorenza Tsansizi [Italie] ; Sebastiano Sciarretta [Italie] ; Julio Madrigal-Matute [États-Unis] | Comprehensive autophagy evaluation in cardiac disease models |
| 000951 |
Kate Wiles [Royaume-Uni] ; Lucy Chappell [Royaume-Uni] ; Katherine Clark [Royaume-Uni] ; Louise Elman [Royaume-Uni] ; Matt Hall [Royaume-Uni] ; Liz Lightstone [Royaume-Uni] ; Germin Mohamed [Royaume-Uni] ; Durba Mukherjee [Royaume-Uni] ; Catherine Nelson-Piercy [Royaume-Uni] ; Philip Webster [Royaume-Uni] ; Rebecca Whybrow [Royaume-Uni] ; Kate Bramham [Royaume-Uni] | Clinical practice guideline on pregnancy and renal disease |
| 000968 |
Tommy Weiss-Sadan ; Gal Itzhak ; Farnusch Kaschani [Allemagne] ; Zhanru Yu [Royaume-Uni] ; Mohamed Mahameed ; Adi Anaki ; Yael Ben-Nun ; Emmanuelle Merquiol ; Boaz Tirosh ; Benedikt Kessler [Royaume-Uni] ; Markus Kaiser [Allemagne] ; Galia Blum | Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation |
| 000975 |
Beatriz Tejera Segura [Royaume-Uni] ; I Igo Rua-Figueroa [Espagne] ; Jose Maria Pego-Reigosa [Espagne] ; Victor Del Campo [Espagne] ; Chris Wincup [Royaume-Uni] ; David Isenberg [Royaume-Uni] ; Anisur Rahman [Royaume-Uni] | Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort |
| 000980 |
Siham Boulisfane-El Khalifi [France] ; Sebastien Viel [France] ; Annie Lahoche [France] ; Marie-Louise Frémond [France] ; Jonathan Lopez [France] ; Christine Lombard [France] ; Francois Dubos [France] ; Héloise Reumaux [France] ; Viviane Gnemmi [France] ; Marie Legendre [France] ; Yanick J. Crow [France, Royaume-Uni] ; Caroline Thumerelle [France] ; Alexandre Belot [France] | COPA Syndrome as a Cause of Lupus Nephritis |
| 000992 |
Avedis Torossian [France] ; Nicolas Broin [France] ; Julie Frentzel [France] ; Camille Daugrois [France] ; Sarah Gandarillas [France] ; Talal Al Saati [France] ; Laurence Lamant [France, Royaume-Uni] ; Pierre Brousset [France, Royaume-Uni] ; Sylvie Giuriato [France, Royaume-Uni, Belgique] ; Estelle Espinos [France, Royaume-Uni] | Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death |
| 000A13 |
Elizabeth K. Benedikz [Royaume-Uni] ; Dalan Bailey [Royaume-Uni] ; Charlotte N. L. Cook [Royaume-Uni] ; Daniel Gonçalves-Carneiro [Royaume-Uni] ; Michelle M. C. Buckner [Royaume-Uni] ; Jessica M. A. Blair [Royaume-Uni] ; Timothy J. Wells [Royaume-Uni] ; Nicola F. Fletcher [Royaume-Uni] ; Margaret Goodall [Royaume-Uni] ; Adriana Flores-Langarica [Royaume-Uni] ; Robert A. Kingsley [Royaume-Uni] ; Jens Madsen [Royaume-Uni] ; Jessica Teeling [Royaume-Uni] ; Sebastian L. Johnston [Royaume-Uni] ; Calman A. Maclennan [Royaume-Uni] ; Peter Balfe [Royaume-Uni] ; Ian R. Henderson [Royaume-Uni] ; Laura J. V. Piddock [Royaume-Uni] ; Adam F. Cunningham [Royaume-Uni] ; Jane A. Mckeating [Royaume-Uni] | Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway |
| 000A86 |
Sofia Avnet [Italie] ; Nicola Baldini [Italie] ; Lucie Brisson [France] ; Stine Falsig Pedersen [Danemark] ; Paolo E. Porporato [Italie] ; Pierre Sonveaux [Belgique] ; Gyorgy Szabadkai [Italie, Royaume-Uni] ; Silvia Pastorekova [Slovaquie] | Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic Adaptations and Targets in Cancer |
| 000B02 |
Eleanor R. Stead [Royaume-Uni] ; Jorge I. Castillo-Quan [États-Unis] ; Victoria Eugenia Martinez Miguel [Royaume-Uni] ; Celia Lujan [Royaume-Uni] ; Robin Ketteler [Royaume-Uni] ; Kerri J. Kinghorn [Royaume-Uni] ; Ivana Bjedov [Royaume-Uni] | Agephagy – Adapting Autophagy for Health During Aging |
| 000B39 |
Sakinah Hassan [Royaume-Uni] ; Karin J. Purdie [Royaume-Uni] ; Jun Wang [Royaume-Uni] ; Catherine A. Harwood [Royaume-Uni] ; Charlotte M. Proby [Royaume-Uni] ; Celine Pourreyron [Royaume-Uni] ; Nikol Mladkova [Royaume-Uni] ; Ai Nagano [Royaume-Uni] ; Sandeep Dhayade [Royaume-Uni] ; Dimitris Athineos [Royaume-Uni] ; Matthew Caley [Royaume-Uni] ; Viviana Mannella [Royaume-Uni] ; Karen Blyth [Royaume-Uni] ; Gareth J. Inman [Royaume-Uni] ; Irene M. Leigh [Royaume-Uni] | A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing |
| 000B71 |
Mariam Al-Attar [Royaume-Uni] ; Rachel Gorodkin [Royaume-Uni] | 9. Hypomyopathic dermatomyositis complicated by mannose-binding lectin deficiency |
| 000B78 |
Elizabeth Clarke [Royaume-Uni] ; Marie Clegg [Royaume-Uni] ; Heather Green [Royaume-Uni] ; Pippa Watson [Royaume-Uni] | 24. Chronic inflammatory arthritis in the context of cystic fibrosis |
| 000C38 |
Dana Wai Yi Tsui [Royaume-Uni] ; Muhammed Murtaza [Royaume-Uni] ; Alvin Seng Cheong Wong [Singapour] ; Oscar M. Rueda [Royaume-Uni] ; Christopher G. Smith [Royaume-Uni] ; Dineika Chandrananda [Royaume-Uni] ; Ross A. Soo [Singapour] ; Hong Liang Lim [Singapour] ; Boon Cher Goh [Singapour] ; Carlos Caldas [Royaume-Uni] ; Tim Forshew [Royaume-Uni] ; Davina Gale [Royaume-Uni] ; Wei Liu [Royaume-Uni] ; James Morris [Royaume-Uni] ; Francesco Marass [Royaume-Uni] ; Tim Eisen [Royaume-Uni] ; Tan Min Chin [Singapour] ; Nitzan Rosenfeld [Singapour] | Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer. |
| 000C67 |
Thais De Oliveira [Brésil] ; Priscila Rodrigues [Brésil] ; Maria Menezes [Brésil] ; Raquel Gonçalves-Lopes [Brésil] ; Melissa Bastos [Brésil] ; Nathália Lima [Brésil] ; Susana Barbosa [Brésil] ; Alexandra Gerber [Brésil] ; Guilherme Loss De Morais [Brésil] ; Luisa Berná [Uruguay] ; Jody Phelan [Royaume-Uni] ; Carlos Robello [Uruguay] ; Ana De Vasconcelos [Brésil] ; João Alves [Brésil] ; Marcelo Ferreira [Brésil] | Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax |
| 000D80 |
Jonathan E. Hiorns [Royaume-Uni] ; Cécile M. Bidan [États-Unis] ; Oliver E. Jensen [Royaume-Uni] ; Reinoud Gosens [Pays-Bas] ; Loes E M. Kistemaker [Pays-Bas] ; Jeffrey J. Fredberg [États-Unis] ; Jim P. Butler [États-Unis] ; Ramaswamy Krishnan [États-Unis] ; Bindi S. Brook [Royaume-Uni] | Airway and Parenchymal Strains during Bronchoconstriction in the Precision Cut Lung Slice. |
| 000E01 |
I. Blanco [Espagne] ; D. Lipsker [France] ; B. Lara [Royaume-Uni] ; S. Janciauskiene [Allemagne] | Neutrophilic panniculitis associated with alpha‐1‐antitrypsin deficiency: an update |
| 000E31 |
M. B. Farooq [Royaume-Uni] ; G. M. Walsh [Royaume-Uni] | Autophagy and Asthma |
| 000E44 |
Serena Pulcini [Royaume-Uni] ; Henry M. Staines [Royaume-Uni] ; Andrew H. Lee [États-Unis] ; Sarah H. Shafik [Australie] ; Guillaume Bouyer [France] ; Catherine M. Moore [Royaume-Uni] ; Daniel A. Daley [États-Unis] ; Matthew J. Hoke [États-Unis] ; Lindsey M. Altenhofen [États-Unis] ; Heather J. Painter [États-Unis] ; Jianbing Mu [États-Unis] ; David J P. Ferguson [Royaume-Uni] ; Manuel Llinas [États-Unis] ; Rowena E. Martin [Australie] ; David A. Fidock [États-Unis] ; Roland A. Cooper [États-Unis] ; Sanjeev Krishna [Royaume-Uni] | Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities |
| 000E46 |
Philippe Guyant [Cambodge] ; Vincent Corbel [Thaïlande] ; Philippe J Guérin [Royaume-Uni] ; Adeline Lautissier [France] ; François Nosten [Royaume-Uni] ; Sébastien Boyer [Madagascar] ; Marc Coosemans [Belgique] ; Arjen M Dondorp [Royaume-Uni] ; Véronique Sinou [France] ; Shunmay Yeung [Royaume-Uni] ; Nicholas White [Royaume-Uni] | Past and new challenges for malaria control and elimination: the role of operational research for innovation in designing interventions |
| 000E88 |
Andrew Bush [Royaume-Uni] ; Steve Cunningham [Royaume-Uni] ; Jacques De Blic [France] ; Angelo Barbato [Italie] ; Annick Clement [France] ; Ralph Epaud [France] ; Meike Hengst [Allemagne] ; Nural Kiper [Turquie] ; Andrew G. Nicholson [Royaume-Uni] ; Martin Wetzke [Allemagne] ; Deborah Snijders [Italie] ; Nicolaus Schwerk [Allemagne] ; Matthias Griese [Allemagne] | European protocols for the diagnosis and initial treatment of interstitial lung disease in children. |
| 000F59 |
Fatma E. Mohamed [Royaume-Uni, Égypte] ; Rajai M. Al-Jehani [Royaume-Uni] ; Shane S. Minogue [Royaume-Uni] ; Fausto Andreola [Royaume-Uni] ; Alison Winstanley [Royaume-Uni] ; Steven W. M. Olde Damink [Royaume-Uni] ; Abeba Habtesion [Royaume-Uni] ; Massimo Malag [Royaume-Uni] ; Nathan Davies [Royaume-Uni] ; Tu Vinh Luong [Royaume-Uni] ; Amar P. Dhillon [Royaume-Uni] ; Rajeshwar P. Mookerjee [Royaume-Uni] ; Dipok K. Dhar [Royaume-Uni] ; Rajiv Jalan [Royaume-Uni] | Effect of toll‐like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma |
| 000F61 |
Tessa L. Holyoake [Royaume-Uni] ; G. Vignir Helgason [Royaume-Uni] | Do we need more drugs for chronic myeloid leukemia? |
| 000F63 |
Ruth O'Reilly [Royaume-Uni] ; David Kilner [Royaume-Uni] ; Michael Ashworth [Royaume-Uni] ; Paul Aurora [Royaume-Uni] | Diffuse lung disease in infants less than 1 year of age: Histopathological diagnoses and clinical outcome |
| 000F77 |
R. J. Powell [Royaume-Uni] ; S. C. Leech [Royaume-Uni] ; S. Till [Royaume-Uni] ; P. A. J. Huber [Royaume-Uni] ; S. M. Nasser [Royaume-Uni] ; A. T. Clark [Royaume-Uni] | BSACI guideline for the management of chronic urticaria and angioedema |
| 000F78 |
Lorenzo Galluzzi [France, Italie] ; Federico Pietrocola [France] ; José Manuel Bravo-San Pedro [France] ; Ravi K. Amaravadi [États-Unis] ; Eric H. Baehrecke [États-Unis] ; Francesco Cecconi [Danemark, Italie] ; Patrice Codogno [France] ; Jayanta Debnath [États-Unis] ; David A. Gewirtz [États-Unis] ; Vassiliki Karantza [États-Unis] ; Alec Kimmelman [États-Unis] ; Sharad Kumar [Australie] ; Beth Levine [États-Unis] ; Maria Chiara Maiuri [France] ; Seamus J. Martin [Irlande (pays)] ; Josef Penninger [Autriche] ; Mauro Piacentini [Italie] ; David C. Rubinsztein [Royaume-Uni] ; Hans-Uwe Simon [Suisse] ; Anne Simonsen [Norvège] ; Andrew M. Thorburn [États-Unis] ; Guillermo Velasco [Espagne] ; Kevin M. Ryan [Royaume-Uni] ; Guido Kroemer [France] | Autophagy in malignant transformation and cancer progression |
| 000F80 |
Mira Merashli [Royaume-Uni] ; Mohammad Hassan A. Noureldine [Liban] ; Imad Uthman [Liban] ; Munther Khamashta [Royaume-Uni] | Antiphospholipid syndrome: an update |
| 001011 |
Simone Ragusa [Suisse] ; Jianpin Cheng [Suisse] ; Konstantin I. Ivanov [Suisse] ; Nadine Zangger [Suisse] ; Fatih Ceteci [Royaume-Uni] ; Jeremiah Bernier-Latmani [Suisse] ; Stavros Milatos [Suisse] ; Jean-Marc Joseph [Suisse] ; Stephane Tercier [Suisse] ; Hanifa Bouzourene [Suisse] ; Fredrik T. Bosman [Suisse] ; Igor Letovanec [Suisse] ; Giancarlo Marra [Suisse] ; Michel Gonzalez [Suisse] ; Patrizia Cammareri [Royaume-Uni] ; Owen J. Sansom [Royaume-Uni] ; Mauro Delorenzi [Suisse] ; Tatiana V. Petrova [Suisse] | PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells. |
| 001021 |
Lisa Jolly [Royaume-Uni] ; Anastasios Stavrou [Royaume-Uni] ; Gilles Vanderstoken [Canada] ; Victoria A. Meliopoulos [États-Unis] ; Anthony Habgood [Royaume-Uni] ; Amanda L. Tatler [Royaume-Uni] ; Joanne Porte [Royaume-Uni] ; Alan Knox [Royaume-Uni] ; Paul Weinreb [États-Unis] ; Shelia Violette [États-Unis] ; Tracy Hussell [Royaume-Uni] ; Martin Kolb [Canada] ; Martin R. Stampfli [Canada] ; Stacey Schultz-Cherry [États-Unis] ; Gisli Jenkins [Royaume-Uni] | Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation. |
| 001029 |
Sivan M. Bokobza [Royaume-Uni] ; Yanyan Jiang ; Anika M. Weber ; Aoife M. Devery ; Anderson J. Ryan [Royaume-Uni] | Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells. |
| 001043 |
John K F. Wong [Royaume-Uni] ; Ross Nortley [Royaume-Uni] ; Thomasin Andrews [Royaume-Uni] ; David D'Cruz [Royaume-Uni] | Psychiatric manifestations of primary Sjögren's syndrome: a case report and literature review |
| 001045 |
Laura Tomlinson [Royaume-Uni] ; Jens Fuchser [Allemagne] ; Arne Fütterer [Allemagne] ; Mark Baumert [Royaume-Uni] ; David G. Hassall [Royaume-Uni] ; Andrew West [Royaume-Uni] ; Peter S. Marshall [Royaume-Uni] | Using a single, high mass resolution mass spectrometry platform to investigate ion suppression effects observed during tissue imaging |
| 001048 |
Michael Williamson [Royaume-Uni] ; Colin Wallis [Royaume-Uni] | Ten‐year follow up of hydroxychloroquine treatment for ABCA3 deficiency |
| 001051 |
S. Rajan [Royaume-Uni] ; Z. Melegh [Royaume-Uni] ; D. De Berker [Royaume-Uni] | Subungual sarcoidosis: a rare entity |
| 001077 |
John O. Suberu [Royaume-Uni] ; Isolda Romero-Canel N [Royaume-Uni] ; Neil Sullivan [Royaume-Uni] ; Alexei A. Lapkin [Royaume-Uni] ; Guy C. Barker [Royaume-Uni] | Comparative Cytotoxicity of Artemisinin and Cisplatin and Their Interactions with Chlorogenic Acids in MCF7 Breast Cancer Cells |
| 001094 |
Charles J. Woodrow [Royaume-Uni] ; Sabina Dahlström [France] ; Richard Cooksey [Royaume-Uni] ; Jennifer A. Flegg [Royaume-Uni] ; Hervé Le Nagard [France] ; France Mentré [France] ; Claribel Murillo [Colombie] ; Didier Ménard [Cambodge] ; François Nosten [Thaïlande] ; Kanlaya Sriprawat [Thaïlande] ; Lise Musset ; Neils B. Quashie [Ghana] ; Pharath Lim [États-Unis] ; Rick M. Fairhurst [États-Unis] ; Sam L. Nsobya [Ouganda] ; Veronique Sinou [France] ; Harald Noedl [Autriche] ; Bruno Pradines [France] ; Jacob D. Johnson [Kenya] ; Philippe J. Guerin [Royaume-Uni] ; Carol H. Sibley [Royaume-Uni] ; Jacques Le Bras [Royaume-Uni] | High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool. |
| 001099 |
Supinya Thanapongpichat [Thaïlande] ; Rose Mcgready [Thaïlande] ; Christine Luxemburger [France] ; Nicholas Day [Royaume-Uni] ; Nicholas White [Royaume-Uni] ; Francois Nosten [Thaïlande] ; Georges Snounou [France] ; Mallika Imwong [Thaïlande] | Microsatellite genotyping of Plasmodium vivax infections and their relapses in pregnant and non-pregnant patients on the Thai-Myanmar border |
| 001100 |
Myriam Gharbi [France] ; Jennifer Flegg [Royaume-Uni] ; Véronique Hubert [France] ; Eric Kendjo [France] ; Jessica Metcalf [Royaume-Uni] ; Lionel Bertaux [France] ; Philippe Guérin [France] ; Jacques Le Bras [France] | Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. |
| 001109 |
S. Walters [Royaume-Uni] ; N. Bhatt ; A R L. Medford | Reversible cerebellar signs due to sarcoid-related severe hypercalcaemia. |
| 001118 |
Lu Long [Royaume-Uni] ; Xudong Yang ; Mark Southwood ; Junyu Lu ; Stefan J. Marciniak ; Benjamin J. Dunmore ; Nicholas W. Morrell | Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. |
| 001133 |
Christopher J M. Whitty [Royaume-Uni] ; Peter L. Chiodini [Royaume-Uni] ; David G. Lalloo [Royaume-Uni] | Investigation and treatment of imported malaria in non-endemic countries |
| 001136 |
Simona Turcu [Royaume-Uni] ; Emma Ashton [Royaume-Uni] ; Lucy Jenkins [Royaume-Uni] ; Atul Gupta [Royaume-Uni] ; Quen Mok [Royaume-Uni] | Genetic testing in children with surfactant dysfunction |
| 001138 |
David G. Samuel [Royaume-Uni] ; Ian W. Rees [Royaume-Uni] | Extrahepatic manifestations of hepatitis C virus (HCV) |
| 001141 |
Cameron Alexander [Royaume-Uni] ; Francisco Fernandez Trillo [Royaume-Uni] | CHAPTER 10 - Bioresponsive Polyplexes and Micelleplexes |
| 001169 |
Mahmoud Dastoori [Royaume-Uni] ; Stefano Fedele [Royaume-Uni] ; Jair C. Leao [Royaume-Uni, Brésil] ; Stephen R. Porter [Royaume-Uni] | Sarcoidosis – a clinically orientated review |
| 001182 |
Beverley J. Hunt [Royaume-Uni] ; Rowena R. Thomas-Dewing ; Kate Bramham [Royaume-Uni] ; Sebastian B. Lucas | Preventing maternal deaths due to acquired thrombotic thrombocytopenic purpura |
| 001204 |
C T Dollery [Royaume-Uni] | Intracellular Drug Concentrations |
| 001216 |
D. A. Pappas [États-Unis] ; M. Hooper ; G. Reed ; Y. Shan ; D. Wenkert ; J. Zhang [Royaume-Uni] ; J. Greenberg [États-Unis] ; J. Curtis [Royaume-Uni] | FRI0108 Risk for herpes zoster after treatment with biologic and synthetic disease modifying agents for rheumatoid arthritis |
| 001217 |
C. O. Bingham [États-Unis] ; W. Rizzo ; M. Klearman [États-Unis] ; A. Hassanali [États-Unis] ; R. Upmanyu [Royaume-Uni] ; A. Kivitz [États-Unis] | FRI0106 Preliminary results from a controlled trial (VISARA) to evaluate the humoural immune response to vaccines in RA patients treated with tocilizumab (TCZ) |
| 001229 |
Farzaneh Salem [Royaume-Uni] ; Amin Rostami-Hodjegan [Royaume-Uni] ; Trevor N. Johnson [Royaume-Uni] | Do Children Have the Same Vulnerability to Metabolic Drug–Drug Interactions as Adults? A Critical Analysis of the Literature |
| 001232 |
J. Zhang ; Q. L. Zhu ; P. Huang [République populaire de Chine] ; Q. Yu ; Z. H. Wang ; P. R. Cooper [Royaume-Uni] ; A. J. Smith [Royaume-Uni] ; W. He [République populaire de Chine] | CpG ODN‐induced matrix metalloproteinase‐13 expression is mediated via activation of the ERK and NF‐κB signalling pathways in odontoblast cells |
| 001273 |
Myriam Gharbi [France] ; Jennifer Flegg [France] ; Véronique Hubert [France] ; Eric Kendjo [France] ; Jessica Metcalf [Royaume-Uni] ; Philippe Guerin [France] ; Jacques Le Bras [France] | Longitudinal study assessing the return of chloroquine susceptibility of Plasmodiun falciparum isolates from travelers returning from West Africa |
| 001291 |
Aurélie Pascual [France] ; Philippe Parola [France] ; Françoise Benoit-Vical [France] ; Fabrice Simon [France] ; Denis Malvy [France] ; Stéphane Picot [France] ; Pascal Delaunay [France] ; Didier Basset [France] ; Danièle Maubon [France] ; Bernard Faugère [France] ; Guillaume Ménard [France] ; Nathalie Bourgeois [France] ; Claude Oeuvray [Suisse] ; Eric Didillon [Royaume-Uni] ; Christophe Rogier [France] ; Bruno Pradines [France] | Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum. |
| 001312 |
F. Mohamed [Royaume-Uni] ; D. Dhar [Royaume-Uni] ; N. Shah [Royaume-Uni] ; N. Davies [Royaume-Uni] ; A. Habtesion [Royaume-Uni] ; T. Luong [Royaume-Uni] ; A. Winstanley [Royaume-Uni] ; A P Dhillon [Royaume-Uni] ; R. Mookerjee [Royaume-Uni] ; R. Jalan [Royaume-Uni] | PMO-092 TLR7 expression is increased in hepatocellular cancer (HCC) and its modulation is associated with alterations in tumour growth: a novel therapeutic target |
| 001313 |
F. Mohamed [Royaume-Uni] ; S. Minogue [Royaume-Uni] ; N. Shah [Royaume-Uni] ; N. Davies [Royaume-Uni] ; A. Habtesion [Royaume-Uni] ; T. Luong [Royaume-Uni] ; A. Winstanley [Royaume-Uni] ; A P Dhillon [Royaume-Uni] ; R. Mookerjee [Royaume-Uni] ; R. Jalan [Royaume-Uni] | PMO-091 TLR 9 inhibition: a novel target of therapy for primary liver cancer |
| 001314 |
C. Chen [Royaume-Uni] ; Q. Zhao [Royaume-Uni] ; J M Rhodes [Royaume-Uni] ; L G Yu [Royaume-Uni] | PMO-090 Galectin-3 induces secretion of cytokines from vascular endothelium that enhance cancer cell-endothelium adhesion: a novel mechanism for galectin-3-mediated metastasis promotion |
| 001317 |
Tia Hunjan [Royaume-Uni] ; Muzzafer Chaudery [Royaume-Uni] ; Ahsan Zaidi [Royaume-Uni] ; Andrew D. Beggs [Royaume-Uni] | Appendicular sarcoidosis mimicking acute appendicitis |
| 001318 |
Matt Gooding [Royaume-Uni] ; Lorcan P. Browne [Royaume-Uni] ; Filipa M. Quinteiro [Royaume-Uni] ; David L. Selwood [Royaume-Uni] | siRNA Delivery: From Lipids to Cell‐penetrating Peptides and Their Mimics |
| 001343 |
Venkata Siva Satyanarayana Kantamreddi [Royaume-Uni] ; Colin W. Wright [Royaume-Uni] | Screening Indian Plant Species for Antiplasmodial Properties – Ethnopharmacological Compared with Random Selection |
| 001353 |
Adam P. Croft [Royaume-Uni] ; Deva Situnayake [Royaume-Uni] ; Omer Khair [Royaume-Uni] ; Gavin Giovanni [Royaume-Uni] ; David Carruthers [Royaume-Uni] ; Arul Sivaguru [Royaume-Uni] ; Caroline Gordon [Royaume-Uni] | Refractory multisystem sarcoidosis responding to infliximab therapy |
| 001362 |
P. Lees [Royaume-Uni] ; R. P. Hunter [États-Unis] ; P. T. Reeves [Australie] ; P. L. Toutain [France] | Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination |
| 001394 |
David Keeling [Royaume-Uni] ; Ian Mackie [Royaume-Uni] ; Gary W. Moore [Royaume-Uni] ; Ian A. Greer [Royaume-Uni] ; Michael Greaves [Royaume-Uni] | Guidelines on the investigation and management of antiphospholipid syndrome |
| 001400 |
J. S. Wee [Royaume-Uni] ; P. J. Shirlaw [Royaume-Uni] ; S. J. Challacombe [Royaume-Uni] ; J. F. Setterfield [Royaume-Uni] | Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients |
| 001402 |
Louise Watson [Royaume-Uni] ; Valentina Leone [Royaume-Uni] ; Clarissa Pilkington [Royaume-Uni] ; Kjell Tullus [Royaume-Uni] ; Satyapal Rangaraj [Royaume-Uni] ; Janet E. Mcdonagh [Royaume-Uni] ; Janet Gardner-Medwin [Royaume-Uni] ; Nick Wilkinson [Royaume-Uni] ; Phil Riley [Royaume-Uni] ; Jane Tizard [Royaume-Uni] ; Kate Armon [Royaume-Uni] ; Manish D. Sinha [Royaume-Uni] ; Yiannis Ioannou [Royaume-Uni] ; Neil Archer [Royaume-Uni] ; Kathryn Bailey [Royaume-Uni] ; Joyce Davidson [Royaume-Uni] ; Eileen M. Baildam [Royaume-Uni] ; Gavin Cleary [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] | Disease activity, severity, and damage in the UK juvenile‐onset systemic lupus erythematosus cohort |
| 001406 |
Fiona L. Dignan [Royaume-Uni] ; Persis Amrolia [Royaume-Uni] ; Andrew Clark [Royaume-Uni] ; Jacqueline Cornish [Royaume-Uni] ; Graham Jackson [Royaume-Uni] ; Prem Mahendra [Royaume-Uni] ; Julia J. Scarisbrick [Royaume-Uni] ; Peter C. Taylor [Royaume-Uni] ; Bronwen E. Shaw [Royaume-Uni] ; Michael N. Potter [Royaume-Uni] | Diagnosis and management of chronic graft‐versus‐host disease |
| 001425 |
David C. Rubinsztein [Royaume-Uni] ; Patrice Codogno [France] ; Beth Levine [États-Unis] | Autophagy modulation as a potential therapeutic target for diverse diseases |
| 001430 |
Alexis Nzila [Afrique du Sud, Royaume-Uni] ; Kelly Chibale [Afrique du Sud] | Anticancer Drug Repositioning Against Tropical Diseases: The Example of Methotrexate in the Treatment of Malaria |
| 001437 |
Luke R. G. Pike [Royaume-Uni] ; Kanchan Phadwal [Royaume-Uni] ; Anna Katharina Simon [Royaume-Uni] ; Adrian L. Harris [Royaume-Uni] | ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia |
| 001448 |
Jenny Calven [Suède] ; Yulyana Yudina [Suède] ; Oskar Hallgren [Suède] ; Gunilla Westergren-Thorsson [Suède] ; Donna E. Davies [Royaume-Uni] ; Angelica Brandelius [Suède] ; Lena Uller [Suède] | Viral Stimuli Trigger Exaggerated Thymic Stromal Lymphopoietin Expression by Chronic Obstructive Pulmonary Disease Epithelium: Role of Endosomal TLR3 and Cytosolic RIG-I-Like Helicases |
| 001462 |
Christophe Biot [France] ; F. Nosten [Royaume-Uni] ; L. Fraisse [France] ; D. Ter-Minassian [France] ; Jamal Khalife [France] ; Daniel Dive [France] | The antimalarial ferroquine: from bench to clinic. |
| 001465 |
Marcus Rijken [Thaïlande] ; Machteld Boel [Thaïlande] ; Bruce Russell [Singapour] ; Mallika Imwong [Thaïlande] ; Mara Leimanis [Thaïlande] ; Aung Phyo [Thaïlande] ; Atis Muehlenbachs [États-Unis] ; Niklas Lindegardh [Royaume-Uni] ; Rose Mcgready [Thaïlande] ; Laurent Rénia [Singapour] ; Georges Snounou [Singapour] ; Pratap Singhasivanon [Thaïlande] ; François Nosten [Thaïlande] | Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand. |
| 001481 |
W G Dixon [Royaume-Uni, Canada] ; A. Kezouh [Canada] ; S. Bernatsky [Canada] ; S. Suissa [Canada] | The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study |
| 001484 |
B J Dunmore [Royaume-Uni] ; L. Long [Royaume-Uni] ; X D Yang [Royaume-Uni] ; A. Crosby [Royaume-Uni] ; N W Morrell [Royaume-Uni] | S99 The anti-malarial drug and lysosomal inhibitor, chloroquine, increases cell surface expression of BMPR-II |
| 001485 |
A. Crosby [Royaume-Uni] ; E. Soon [Royaume-Uni] ; F. Jones [Royaume-Uni] ; M. Southwood [Royaume-Uni] ; B. Dunmore [Royaume-Uni] ; D. Dunne [Royaume-Uni] ; N W Morrell [Royaume-Uni] | S98 BMPR-II mutations do not predispose to pulmonary arterial hypertension in a mouse model of schistosomiasis |
| 001486 |
L. Long [Royaume-Uni] ; X. Yang [Royaume-Uni] ; N W Morrell [Royaume-Uni] ; M. Southwood [Royaume-Uni] | S97 BMPR2 R899X knock-in mice developed age-related pulmonary hypertension |
| 001487 |
K. Schreiber [Royaume-Uni] ; O. Ateka-Barrutia [Royaume-Uni] ; Ma Khamashta [Royaume-Uni] ; Grv Hughes [Royaume-Uni] | OBSTETRIC ANTIPHOSPHOLIPID SYNDROME - A REVIEW |
| 001488 |
Kulveer S. Mankia [Royaume-Uni] ; Joel David [Royaume-Uni] | A diagnosis of sarcoid arthritis: ‘check the tattoos’ |
| 001492 |
V. Neves [Royaume-Uni] ; H. M. Coley [Royaume-Uni] ; J. Mcfadden [Royaume-Uni] ; S. R. P. Silva [Royaume-Uni] | Uptake, Intracellular Localization and Biodistribution of Carbon Nanotubes |
| 001495 |
James E. Peters [Royaume-Uni] ; Christopher J. Burke [Royaume-Uni] ; Vanessa H. Morris [Royaume-Uni] | Three cases of rheumatoid arthritis with laryngeal stridor |
| 001545 |
Guillermo Ruiz-Irastorza [Espagne] ; Munther A. Khamashta [Royaume-Uni] | Lupus and pregnancy: integrating clues from the bench and bedside |
| 001552 |
Katarzyna R. Przybylak [Royaume-Uni] ; Mark T. D. Cronin [Royaume-Uni] | In Silico Studies of the Relationship Between Chemical Structure and Drug Induced Phospholipidosis |
| 001556 |
Navtej Sathi [Royaume-Uni] ; Batsirai Chikura [Royaume-Uni] ; Viswanath V. Kaushik [Royaume-Uni] ; Rose Wiswell [Royaume-Uni] ; Julie K. Dawson [Royaume-Uni] | How common is methotrexate pneumonitis? A large prospective study investigates |
| 001560 |
Muir Morton [Royaume-Uni] ; Sarah Edmonds [Royaume-Uni] ; Aislinn M. Doherty [Royaume-Uni] ; Ajay Dhaygude [Royaume-Uni] ; Matthew Helbert [Royaume-Uni] ; Mike Venning [Royaume-Uni] | Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement |
| 001563 |
Sevda Süzgeç-Selçuk [Turquie] ; Ali H. Meriçli [Turquie] ; Kas M C. Güven [Turquie] ; Marcel Kaiser [Suisse] ; Rosalyn Casey [Royaume-Uni] ; Suzie Hingley-Wilson [Royaume-Uni] ; Ajit Lalvani [Royaume-Uni] ; Deniz Tasdemir [Royaume-Uni] | Evaluation of Turkish seaweeds for antiprotozoal, antimycobacterial and cytotoxic activities |
| 001571 |
Amy R. Wyatt [Australie] ; Justin J. Yerbury [Australie] ; Paula Berghofer [Australie] ; Ivan Greguric [Australie] ; Andrew Katsifis [Australie] ; Christopher M. Dobson [Royaume-Uni] ; Mark R. Wilson [Australie] | Clusterin facilitates in vivo clearance of extracellular misfolded proteins |
| 001576 |
Julius Clemence Hafalla [Royaume-Uni, Allemagne] ; Olivier Silvie [Allemagne, France] ; Kai Matuschewski [Allemagne] | Cell biology and immunology of malaria |
| 001589 |
Zaid Zoumot [Royaume-Uni] ; Bhupinder S. Mann [Royaume-Uni] | A severe case of multisystem sarcoidosis complicated by aspergillosis and aspergillomas |
| 001591 |
Adrian Waite [Royaume-Uni] ; Maria Cristina De Rosa [Italie] ; Andrea Brancaccio [Italie] ; Derek J. Blake [Royaume-Uni] | A gain‐of‐glycosylation mutation associated with myoclonus‐dystonia syndrome affects trafficking and processing of mouse ε‐sarcoglycan in the late secretory pathway |
| 001601 |
Rosamund Partlett [Royaume-Uni] ; Euthalia Roussou [Royaume-Uni] | The treatment of rheumatoid arthritis during pregnancy |
| 001632 |
Simon L F. Walsh [Royaume-Uni] ; Benjamin J. Roberton [Royaume-Uni] | The atoll sign |
| 001637 |
Barbara Kasprzyk-Hordern [Royaume-Uni] | Pharmacologically active compounds in the environment and their chirality |
| 001640 |
Z. Paskins [Royaume-Uni] ; Sn Kamath [Royaume-Uni] ; Ab Hassell [Royaume-Uni] | Management of inflammatory arthritis in older people |
| 001643 |
M. Mosca [Italie] ; C. Tani [Italie] ; M. Aringer [Allemagne] ; S. Bombardieri [Italie] ; D. Boumpas [Grèce] ; R. Brey [États-Unis] ; R. Cervera [Espagne] ; A. Doria [Italie] ; D. Jayne [Royaume-Uni] ; M A Khamashta [Royaume-Uni] ; A. Kuhn [Allemagne] ; C. Gordon [Royaume-Uni] ; M. Petri [États-Unis] ; O P Rekvig [Norvège] ; M. Schneider [Allemagne] ; Y. Sherer [Israël] ; Y. Shoenfeld [Israël] ; J S Smolen [Autriche] ; R. Talarico [Italie] ; A. Tincani [Italie] ; R F Van Vollenhoven [Suède] ; M M Ward [États-Unis] ; V P Werth [États-Unis] ; L. Carmona [Espagne] | European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies |
| 001644 |
Lena Uller [Royaume-Uni, Suède] ; Marina Leino [Royaume-Uni] ; Nicole Bedke [Royaume-Uni] ; David Sammut [Royaume-Uni] ; Ben Green [Royaume-Uni] ; Laurie Lau [Royaume-Uni] ; Peter H. Howarth [Royaume-Uni] ; Stephen T. Holgate [Royaume-Uni] ; Donna E. Davies [Royaume-Uni] | Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-β in bronchial epithelial cells from donors with asthma |
| 001649 |
D. K. Walker [Royaume-Uni] ; R. M. Jones [Royaume-Uni] ; A. N. R. Nedderman [Royaume-Uni] ; P. A. Wright [Royaume-Uni] | Chapter 4 - Primary, Secondary and Tertiary Amines and their Isosteres |
| 001651 |
Clare Seiber [Royaume-Uni] ; Sandeep Bawa [Royaume-Uni] ; David Ritchie [Royaume-Uni] ; Sandeep Mukherjee [Royaume-Uni] ; Kristoffer Ostridge [Royaume-Uni] ; Katherine Spinks [Royaume-Uni] ; Ernest Wong [Royaume-Uni] ; Mark Edwards [Royaume-Uni] ; Joanna Ledingham [Royaume-Uni] ; Chandhri S. Wijesooriya [Royaume-Uni] ; Anurag N. Bharadwaj [Royaume-Uni] ; Adikesavalu Anilkumar [Royaume-Uni] ; Nagui S. Gendi [Royaume-Uni] ; Sarah J. Evans [Royaume-Uni] ; Martin Bevan [Royaume-Uni] ; Keightley R. Adams [Royaume-Uni] ; Robin Hunter [Royaume-Uni] ; Lois Craddock [Royaume-Uni] ; Caroline Ali [Royaume-Uni] ; Nora Ng [Royaume-Uni] ; Robert Colaco [Royaume-Uni] ; Erden Ali [Royaume-Uni] ; C. Bernard Colaco [Royaume-Uni] ; Vijay Kr Rao [Royaume-Uni] ; Robin Butler [Royaume-Uni] ; Verena Matschke [Royaume-Uni] ; Jeremy G. Jones [Royaume-Uni] ; Andrew B. Lemmey [Royaume-Uni] ; Peter J. Maddison [Royaume-Uni] ; Jeanette M. Thom [Royaume-Uni] ; Muhammad Haroon [Royaume-Uni] ; Ahmed Eltahir [Royaume-Uni] ; Sinead Harney [Royaume-Uni] ; Arumugham Moorthy [Royaume-Uni] ; Mudita Tripathi [Royaume-Uni] ; George Hirsch [Royaume-Uni] ; Adrian Pace [Royaume-Uni] ; Wing Hoi Yau [Royaume-Uni] ; Helen Cohen [Royaume-Uni] ; Candy Mccabe [Royaume-Uni] ; Neil Mo [Royaume-Uni] ; Margaret O'Sullivan [Royaume-Uni] ; Emma Williams [Royaume-Uni] ; Joanna Ledingham [Royaume-Uni] ; Catherine Gwynne [Royaume-Uni] ; Sarah Hale [Royaume-Uni] ; Anurag Negi [Royaume-Uni] ; Emyr Humphreys [Royaume-Uni] ; Julian Nash [Royaume-Uni] ; Aruna S. Malipeddi [Royaume-Uni] ; Rebecca Neame [Royaume-Uni] ; Anurag Bharadwaj [Royaume-Uni] ; Nagui Gendi [Royaume-Uni] ; Abdel Abdulla [Royaume-Uni] ; Amel Ginawi [Royaume-Uni] ; Anshuman P. Malaviya [Royaume-Uni] ; Bhaskar Dasgupta [Royaume-Uni] ; Sudipto Das [Royaume-Uni] ; Ai Lyn Tan [Royaume-Uni] ; Sarah Miles [Royaume-Uni] ; Lesley Hordon [Royaume-Uni] ; Nurani Sivaramakrishhan [Royaume-Uni] | Case Reports [3–24] |
| 001662 |
John D. Isaacs [Royaume-Uni] | The changing face of rheumatoid arthritis: sustained remission for all? |
| 001665 |
Martin A. Lee [Royaume-Uni] ; David G. Hutchinson [Royaume-Uni] | Spontaneous pneumomediastinum secondary to refractory dermatomyositis successfully treated with rituximab |
| 001670 |
V. Navaratnam [Royaume-Uni] ; N. Ali [Royaume-Uni] ; Cjp Smith [Royaume-Uni] ; A. Fogarty [Royaume-Uni] ; R B Hubbard [Royaume-Uni] | S55 Pulmonary fibrosis with and without co-existing connective tissue disease: does it affect survival? |
| 001671 |
R K Coker [Royaume-Uni] ; C. Wang [Royaume-Uni] ; A. Sepahzad [Royaume-Uni] ; N J Roberts [Royaume-Uni] ; M R Partridge [Royaume-Uni] | S54 Characterising sarcoidosis using a web-based registry: a pilot study |
| 001677 |
Tracey E. Toms [Royaume-Uni] ; Jacqueline P. Smith [Royaume-Uni] ; Vasileios F. Panoulas [Royaume-Uni] ; Karen M. J. Douglas [Royaume-Uni] ; Athanasios N. Saratzis [Royaume-Uni] ; George D. Kitas [Royaume-Uni] | Prevalence of risk factors for statin‐induced myopathy in rheumatoid arthritis patients |
| 001691 |
Stephen L. Hart [Royaume-Uni] | Multifunctional nanocomplexes for gene transfer and gene therapy |
| 001692 |
Stephen D. Marks [Royaume-Uni] ; Kjell Tullus [Royaume-Uni] | Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis |
| 001748 |
Ana M. Pizarro [Royaume-Uni] ; Abraha Habtemariam [Royaume-Uni] ; Peter J. Sadler [Royaume-Uni] | Activation Mechanisms for Organometallic Anticancer Complexes |
| 001751 |
B. Collin [Royaume-Uni] ; R. Rajaratnam [Royaume-Uni] ; R. Lim [Royaume-Uni] ; H. Lewis [Royaume-Uni] | A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department |
| 001759 |
Elizabeth Stringer [Canada, États-Unis, Royaume-Uni] ; John Bohnsack ; Suzanne L. Bowyer ; Thomas A. Griffin ; Adam M. Huber ; Bianca Lang ; Carol B. Lindsley ; Sylvia Ota ; Clarissa Pilkington ; Ann M. Reed ; Rosie Scuccimarri ; Brian M. Feldman | Treatment Approaches to Juvenile Dermatomyositis (JDM) Across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey |
| 001785 |
J. K. Roe [Royaume-Uni] ; G. Pasvol [Royaume-Uni] | New developments in the management of malaria in adults |
| 001787 |
N. Syed [Royaume-Uni] ; A. Saxena [Royaume-Uni] ; L. Hartley [Royaume-Uni] | Investigating chronic meningitis |
| 001790 |
Shahir S. Hamdulay [Royaume-Uni] ; Justin C. Mason [Royaume-Uni] | Disease-modifying anti-rheumatic drugs: do they reduce cardiac complications of RA? |
| 001791 |
P. N. Vuong [France] ; F. Richard [France] ; G. Snounou [Royaume-Uni] ; F. Coquelin [France] ; L. Rénia [France] ; F. Gonnet [France] ; A. G. Chabaud [France] ; I. Landau [France] | Development of irreversible lesions in the brain, heart and kidney following acute and chronic murine malaria infection |
| 001794 |
Joseph J. Magadula [Tanzanie, Royaume-Uni] ; Paul Erasto [Tanzanie, Royaume-Uni] | Bioactive natural products derived from the East African flora |
| 001809 |
James Wentworth [Royaume-Uni] ; Clare Davies | Systemic lupus erythematosus |
| 001818 |
F. Goldblatt [Royaume-Uni] ; S. Chambers [Royaume-Uni] ; A. Rahman [Royaume-Uni] ; Da Isenberg [Royaume-Uni] | Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality |
| 001820 |
Andrew D. Duckworth [Royaume-Uni] ; Adam T. Hill [Royaume-Uni] ; Ian Beggs [Royaume-Uni] ; James T. Patton [Royaume-Uni] ; Donald M. Salter [Royaume-Uni] ; Daniel E. Porter [Royaume-Uni] | Sarcoidosis Presenting as a Proximal Phalangeal Bony Swelling—a Case and Review of the Literature |
| 001844 |
V. Ravindran [Royaume-Uni] ; O. Duke [Royaume-Uni] | Non-tropical pyomyositis in a patient with systemic lupus erythematosus |
| 001846 |
F G Joseph [Royaume-Uni] ; N J Scolding [Royaume-Uni] | Neurosarcoidosis: a study of 30 new cases |
| 001854 |
Natasha Behrendorff [Australie] ; Alka Shukla [Australie] ; Christof Schwiening [Royaume-Uni] ; Peter Thorn [Australie] | Local dynamic changes in confined extracellular environments within organs |
| 001865 |
R. Smith [Royaume-Uni] ; J. Haeney [Royaume-Uni] ; Kh. Gulraiz Rauf [Royaume-Uni] | Improving cosmesis of lupus pernio by excision and forehead flap reconstruction |
| 001873 |
Ja Reynolds [Royaume-Uni] ; V. Toescu [Royaume-Uni] ; Cs Yee [Royaume-Uni] ; A. Prabu [Royaume-Uni] ; D. Situnayake [Royaume-Uni] ; C. Gordon [Royaume-Uni] | Effects of rituximab on resistant SLE disease including lung involvement |
| 001885 |
Catherine Goodman [Royaume-Uni, Kenya] ; S. Patrick Kachur [États-Unis] ; Salim Abdulla [Tanzanie] ; Peter Bloland [États-Unis] ; Anne Mills [Royaume-Uni] | Concentration and drug prices in the retail market for malaria treatment in rural Tanzania |
| 001897 |
A. Abdul-Wahab ; C. A. Holden ; C. Harland ; S. Patel [Royaume-Uni] | Calcific panniculitis in adult‐onset dermatomyositis |
| 001900 |
Djalma A. P. Dos Santos [Brésil] ; Patricia A. De C. Braga [Brésil] ; M. Fátima Das G. F. Da Silva [Brésil] ; João B. Fernandes [Brésil] ; Paulo C. Vieira [Brésil] ; Aderbal F. Magalhães [Brésil] ; Eva G. Magalhães [Brésil] ; Anita J. Marsaioli [Brésil] ; Valéria R. De S. Moraes [Brésil] ; Lauren Rattray [Royaume-Uni] ; Simon L. Croft [Royaume-Uni] | Anti‐African trypanocidal and antimalarial activity of natural flavonoids, dibenzoylmethanes and synthetic analogues |
| 001933 |
Gemma L. Ellis [Espagne] ; Richard Amewu [Espagne] ; Sunil Sabbani [Espagne] ; Paul A. Stocks [Espagne] ; Alison Shone [Espagne] ; Deborah Stanford [Espagne] ; Peter Gibbons [Espagne] ; Jill Davies [Espagne] ; Livia Vivas [Espagne] ; Sarah Charnaud [Espagne] ; Emily Bongard [Espagne] ; Charlotte Hall [Espagne] ; Karen Rimmer [Espagne] ; Sonia Lozanom [Espagne] ; María Jesús [Espagne] ; Domingo Gargallo [Espagne] ; Stephen A. Ward [Espagne] ; Paul M. O Eill [Espagne, Royaume-Uni] | Two-Step Synthesis of Achiral Dispiro-1,2,4,5-tetraoxanes with Outstanding Antimalarial Activity, Low Toxicity, and High-Stability Profiles |
| 001940 |
Adrian Covic [Roumanie] ; Paul Gusbeth-Tatomir [Roumanie] ; David Goldsmith [Royaume-Uni] | Reply |
| 001943 |
Feiko O. Ter Kuile [Royaume-Uni] ; Stephen J. Rogerson [Australie] | Plasmodium vivax Infection during Pregnancy: An Important Problem in Need of New Solutions |
| 001945 |
Clara J. Day ; Graham W. Lipkin ; Caroline O. S. Savage [Royaume-Uni] | Lupus nephritis and pregnancy in the 21st century |
| 001954 |
Elaine C. Jolly [Royaume-Uni] ; Beverley J. Hunt [Royaume-Uni] ; Spencer Ellis [Royaume-Uni] ; Malcolm Griffiths [Royaume-Uni] ; Ken Farrington [Royaume-Uni] | “Benign” hypergammaglobulinemic purpura is not benign in pregnancy |
| 001959 |
S. Bernatsky [Canada] ; L. Joseph [Canada] ; J-F Boivin [Canada] ; C. Gordon [Canada] ; M. Urowitz [États-Unis] ; D. Gladman [États-Unis] ; P R Fortin [États-Unis] ; E. Ginzler [Corée du Sud] ; S-C Bae [Canada] ; S. Barr [Royaume-Uni] ; S. Edworthy [Royaume-Uni] ; D. Isenberg [États-Unis] ; A. Rahman [États-Unis] ; M. Petri [États-Unis] ; G S Alarc N [États-Unis] ; C. Aranow [États-Unis] ; M-A Dooley [Canada] ; R. Rajan [Canada] ; J-L Sénécal [Canada] ; M. Zummer [États-Unis] ; S. Manzi [États-Unis] ; R. Ramsey-Goldman [Canada, Royaume-Uni, États-Unis, Corée du Sud] ; A E Clarke [Canada] | The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study |
| 001972 |
T Y-T Lu [Royaume-Uni] ; T. Jonsdottir [Suède] ; R F Van Vollenhoven [Suède] ; D A Isenberg [Royaume-Uni] | Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases |
| 001981 |
E. C. Veysey [Royaume-Uni] ; J. D. Wilkinson [Royaume-Uni] | Mycosis fungoides masquerading as cutaneous lupus erythematosus and associated with antiphospholipid syndrome |
| 001986 |
G. Ruiz-Irastorza [Espagne] ; Ma Khamashta [Royaume-Uni] | Lupus and pregnancy: ten questions and some answers |
| 001A01 |
S. Chambers [Royaume-Uni] ; R. Raine [Royaume-Uni] ; A. Rahman [Royaume-Uni] ; K. Hagley [Jamaïque] ; K. De Ceulaer [Jamaïque] ; D. Isenberg [Royaume-Uni] | Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica |
| 001A09 |
G. Bertsias [Grèce] ; J P A. Ioannidis [Grèce] ; J. Boletis [Grèce] ; S. Bombardieri [Italie] ; R. Cervera [Espagne] ; C. Dostal [République tchèque] ; J. Font [Espagne] ; I M Gilboe [Norvège] ; F. Houssiau [Belgique] ; T. Huizinga [Pays-Bas] ; D. Isenberg [Royaume-Uni] ; C G M. Kallenberg [Pays-Bas] ; M. Khamashta [Royaume-Uni] ; J C Piette [France] ; M. Schneider [Allemagne] ; J. Smolen [Autriche] ; G. Sturfelt [Suède] ; A. Tincani [Italie] ; R. Van Vollenhoven [Suède] ; C. Gordon [Royaume-Uni] ; D T Boumpas [Grèce] | EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics |
| 001A38 |
Shanthi Paramothayan [Royaume-Uni] ; Toby Lasserson [Royaume-Uni] | Treatments for pulmonary sarcoidosis |
| 001A61 |
S. J. Bowman [Royaume-Uni] ; N. Sutcliffe [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] ; F. Goldblatt [Royaume-Uni] ; M. Adler [Royaume-Uni] ; E. Price [Royaume-Uni] ; A. Canavan [Royaume-Uni] ; J. Hamburger [Royaume-Uni] ; A. Richards [Royaume-Uni] ; S. Rauz [Royaume-Uni] ; M. Regan [Royaume-Uni] ; K. Gadsby [Royaume-Uni] ; S. Rigby [Royaume-Uni] ; A. Jones [Royaume-Uni] ; R. Mathew [Royaume-Uni] ; D. Mulherin [Royaume-Uni] ; A. Stevenson [Royaume-Uni] ; P. Nightingale [Royaume-Uni] | Sjögren's Systemic Clinical Activity Index (SCAI)—a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome |
| 001A63 |
L. J. Mccann [Argentine, Royaume-Uni] ; S. M. Garay [Argentine] ; M. M. Ryan [Argentine] ; R. Harris [Argentine] ; P. Riley [Argentine] ; C. A. Pilkington [Argentine] | Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores |
| 001A64 |
David Hilton-Jones [Royaume-Uni] ; Maxwell S. Damian [Royaume-Uni] | Myopathies in the older patient |
| 001A66 |
K. Collins [Royaume-Uni] ; H. Aspey [Royaume-Uni] ; A. Todd [Royaume-Uni] ; V. Saravanan [Royaume-Uni] ; M. Rynne [Royaume-Uni] ; C. Kelly [Royaume-Uni] | Methotrexate pneumonitis precipitated by switching from oral to parenteral administration |
| 001A68 |
Nicholas M. Anstey [Australie] ; Tjandra Handojo ; Michael C. F. Pain [Australie] ; Enny Kenangalem [Australie] ; Emiliana Tjitra [Indonésie] ; Ric N. Price [Royaume-Uni] ; Graeme P. Maguire [Australie] | Lung Injury in Vivax Malaria: Pathophysiological Evidence for Pulmonary Vascular Sequestration and Posttreatment Alveolar-Capillary Inflammation |
| 001A74 |
David L. Scott [Royaume-Uni] | Early rheumatoid arthritis |
| 001A75 |
Catherine Goodman [Royaume-Uni, Kenya] ; S Patrick Kachur [Tanzanie, États-Unis] ; Salim Abdulla [Tanzanie] ; Peter Bloland [États-Unis] ; Anne Mills [Royaume-Uni] | Drug shop regulation and malaria treatment in Tanzania—why do shops break the rules, and does it matter? |
| 001A79 |
M. Prendergast [Royaume-Uni] ; N. Hopkinson [Royaume-Uni] | Breast calcinosis, panniculitis and fat hypertrophy in a 35-year-old woman with dermatomyositis |
| 001A81 |
C. M. Everett [Royaume-Uni] ; T. D. Graves [Royaume-Uni] ; S. Lad [Royaume-Uni] ; H. R. J Ger [Royaume-Uni] ; M. Thom [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] ; M. G. Hanna [Royaume-Uni] | Aggressive CNS lupus vasculitis in the absence of systemic disease activity |
| 001A82 |
Laura Price [Royaume-Uni] ; Tim Planche [Royaume-Uni] ; Charlotte Rayner [Royaume-Uni] ; Sanjeev Krishna [Royaume-Uni] | Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature |
| 001A88 |
C. M. Green [Royaume-Uni] | Topical tacrolimus for the treatment of cutaneous sarcoidosis |
| 001A98 |
Z. F. Jasim [Royaume-Uni] ; M. Y. Walsh [Royaume-Uni] ; D. K. B. Armstrong [Royaume-Uni] | Subacute lupus erythematosus‐like rash associated with oesophageal adenocarcinoma in situ |
| 001B01 |
Hongmei Gao [Royaume-Uni] ; Susannah K. Leaver [Royaume-Uni] ; Anne Burke-Gaffney [Royaume-Uni] ; Simon J. Finney [Royaume-Uni] | Severe sepsis and Toll-like receptors |
| 001B03 |
F G Joseph [Royaume-Uni] ; N J Scolding [Royaume-Uni] | Sarcoidosis of the nervous system |
| 001B04 |
Simon W. Dubrey [Royaume-Uni] ; Alex Bell [Royaume-Uni] ; Tarun K. Mittal | Sarcoid heart disease |
| 001B16 |
Richard Haynes [Hong Kong] ; Ho-Ning Wong ; Kin-Wo Lee ; Chung-Man Lung ; Lai Yung Shek ; Ian Williams ; Simon Croft [Royaume-Uni] ; Livia Vivas [Royaume-Uni] ; Lauren Rattray [Royaume-Uni] ; Lindsay Stewart [Royaume-Uni] ; Vincent Wong [République populaire de Chine] ; Ben Ko [République populaire de Chine] | Preparation of N‐Sulfonyl‐ and N‐Carbonyl‐11‐Azaartemisinins with Greatly Enhanced Thermal Stabilities: in vitro Antimalarial Activities |
| 001B19 |
Roberto Lande ; Josh Gregorio ; Valeria Facchinetti ; Bithi Chatterjee [États-Unis] ; Yi-Hong Wang ; Bernhard Homey [Allemagne] ; Wei Cao ; Yui-Hsi Wang ; Bing Su ; Frank O. Nestle [Royaume-Uni] ; Tomasz Zal ; Ira Mellman [États-Unis] ; Jens-Michael Schröder [Allemagne] ; Yong-Jun Liu ; Michel Gilliet [États-Unis] | Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide |
| 001B32 |
R N Jois [Royaume-Uni] ; K. Gaffney [Royaume-Uni] ; P. Cane [Royaume-Uni] ; A G Nicholson [Royaume-Uni] ; A C Wotherspoon [Royaume-Uni] | Methotrexate‐associated lymphoproliferative disorder masquerading as interstitial lung disease |
| 001B74 |
Neil J. Mortimer [Royaume-Uni] ; Michael J. Sladden [Royaume-Uni] ; Sarah E. Hill [Nouvelle-Zélande] ; Robin Ac Graham-Brown [Royaume-Uni] | Childhood sarcoidosis presenting with extensive cutaneous lesions, bilateral hilar lymphadenopathy and severe hypercalcaemia |
| 001C21 |
John G. Hardy [États-Unis] ; Mauri A. Kostiainen [États-Unis] ; David K. Smith [États-Unis, Royaume-Uni] ; Nathan P. Gabrielson [États-Unis] ; Daniel W. Pack [États-Unis] | Dendrons with Spermine Surface Groups as Potential Building Blocks for Nonviral Vectors in Gene Therapy |
| 001C22 |
Al Nicolle [Royaume-Uni] ; Kl Talks [Royaume-Uni] ; Jp Hanley [Royaume-Uni] | Congenital and acquired bleeding problems in elderly patients |
| 001C26 |
S. Patiar [Royaume-Uni] ; J D Ramsden [Royaume-Uni] ; A P Freeland [Royaume-Uni] | B-cell lymphoma of the larynx in a patient with rheumatoid arthritis |
| 001C34 |
Esha Saha [Royaume-Uni] ; Magdalena Dziadzio [Royaume-Uni, Niger] ; Katherine Irving [Royaume-Uni] ; Anthony Chambers [Royaume-Uni] ; Clare Higgens [Royaume-Uni] | Unusual cause of painful shoulder in an elderly woman with rheumatoid arthritis |
| 001C35 |
A C Cordeiro [Portugal] ; D A Isenberg [Royaume-Uni] | Treatment of inflammatory myopathies |
| 001C46 |
Chris Deighton [Royaume-Uni] ; Kate Gadsby [Royaume-Uni] | The new British Society for Rheumatology disease modifying anti‐rheumatic drugs guidelines |
| 001C49 |
A. Nagra [Royaume-Uni] ; M A Saleem [Royaume-Uni] ; A V Ramanan [Royaume-Uni] | The disease with a thousand faces |
| 001C52 |
D J Dhasmana [Royaume-Uni] ; J. Nash [Royaume-Uni] ; J C Bradley [Royaume-Uni] ; D. Creer [Royaume-Uni] | TB screening and anti-TNFα treatment [Letters to the editor] |
| 001C69 |
C A Lee [Royaume-Uni] ; D. Mistry [Royaume-Uni] ; R. Sharma [Royaume-Uni] ; A P Coatesworth [Royaume-Uni] | Rhinological, laryngological, oropharyngeal and other head and neck side effects of drugs |
| 001C71 |
K P Ng [Royaume-Uni] ; M J Leandro [Royaume-Uni] ; J C Edwards [Royaume-Uni] ; M R Ehrenstein [Royaume-Uni] ; G. Cambridge [Royaume-Uni] ; D A Isenberg [Royaume-Uni] | Repeated B cell depletion in treatment of refractory systemic lupus erythematosus |
| 001C73 |
K. A. Finucane [Royaume-Uni] ; C. B. Archer [Royaume-Uni] | Recent advances in haematology and oncology: graft‐versus‐host disease, classification and treatment of non‐Hodgkin's lymphomas, and sentinel‐node biopsy in breast cancer |
| 001D07 |
N. B. O'Donoghue [Royaume-Uni] ; R. J. Barlow [Royaume-Uni] | Laser remodelling of nodular nasal lupus pernio |
| 001D10 |
Alison Jordan [Royaume-Uni] ; Janet E. Mcdonagh [Royaume-Uni] | Juvenile idiopathic arthritis: the paediatric perspective |
| 001D16 |
Alison L. Nightingale [Royaume-Uni] ; Richard D. T. Farmer [Royaume-Uni] ; Corinne S. De Vries [Royaume-Uni] | Incidence of clinically diagnosed systemic lupus erythematosus 1992–1998 using the UK General Practice Research Database |
| 001D17 |
M. N. Lazarus [Royaume-Uni] ; D. Robinson [Royaume-Uni] ; V. Mak [Royaume-Uni] ; H. M Ller [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | Incidence of cancer in a cohort of patients with primary Sjögren's syndrome |
| 001D49 |
K M J. Douglas [Royaume-Uni] ; E. Ladoyanni ; G J Treharne [Royaume-Uni] ; E D Hale [Royaume-Uni] ; N. Erb [Royaume-Uni] ; G D Kitas [Royaume-Uni] | Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions |
| 001D88 |
Mark Wood [Royaume-Uni] ; Ruth Wyllie [Royaume-Uni] ; Helen Foster [Royaume-Uni] | A balancing act |
| 001D90 |
Philip J. Hughes [Royaume-Uni] ; Geoffrey Brown [Royaume-Uni] | 1α,25‐dihydroxyvitamin D3‐mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc‐mediated activation of the RAS/RAF/ERK‐MAP kinase signalling pathway |
| 001E15 |
Paul N. Newton [Laos, Royaume-Uni] ; Nicholas P. J. Day [Laos, Royaume-Uni, Thaïlande] ; Nicholas J. White [Laos, Royaume-Uni, Thaïlande] | Misattribution of Central Nervous System Dysfunction to Artesunate |
| 001E19 |
Manica Balasegaram [Royaume-Uni] ; Seyoum Dejene [Royaume-Uni] ; Peter Tinnemann [Royaume-Uni] ; Samantha Perkins [Royaume-Uni] ; Robert Davidson [Royaume-Uni] | Examples of tropical disease control in the humanitarian medical programmes of MSF and Merlin |
| 001E20 |
I. N. Bruce [Royaume-Uni] | ‘Not only…but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus |
| 001E22 |
K. A. Short [Royaume-Uni] ; E. M. Higgins [Royaume-Uni] | Urticaria as a side‐effect of diphencyprone therapy for resistant viral warts |
| 001E35 |
S. I. Chaudhry [Royaume-Uni] ; L. Murphy [Royaume-Uni] ; I. R. White [Royaume-Uni] | Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis? |
| 001E42 |
Y. Ioannou [Royaume-Uni] ; S J Bowman [Royaume-Uni] ; A. Rahman [Royaume-Uni] ; I P Giles [Royaume-Uni] | Review of presentations at the 6th European Lupus Meeting 3-5 March 2005 |
| 001E44 |
T-H. Yen [Taïwan, Royaume-Uni] ; P-C. Lai [Taïwan] ; C-C. Chen [Taïwan] ; S. Hsueh [Taïwan] ; J-Y. Huang [Taïwan] | Renal involvement in patients with polymyositis and dermatomyositis |
| 001E57 |
C. J. Corrigan ; R. J. Shiner [Royaume-Uni] ; B. H. Shakur [Royaume-Uni] ; P. W. Ind [Royaume-Uni] | Methotrexate therapy of oral corticosteroid‐dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy |
| 001E84 |
A. Mitra ; B. Pollock ; J. Gooi ; J. C. Darling ; A. Boon [Royaume-Uni] ; J. A. Newton-Bishop | Cutaneous granulomas associated with primary immunodeficiency disorders |
| 001E91 |
E. Suresh [Royaume-Uni] ; C M Lambert [Royaume-Uni] | Combination treatment strategies in early rheumatoid arthritis |
| 001E94 |
M W Beresford ; A G Cleary [Royaume-Uni] ; J A Sills [Royaume-Uni] ; J. Couriel [Royaume-Uni] ; J E Davidson [Royaume-Uni] | Cardio-pulmonary involvement in juvenile systemic lupus erythematosus |
| 001E97 |
T. Kennedy ; C. Mccabe ; G. Struthers ; H. Sinclair ; K. Chakravaty ; D. Bax ; M. Shipley ; R. Abernethy ; T. Palferman [Royaume-Uni] ; R. Hull [Royaume-Uni] | BSR guidelines on standards of care for persons with rheumatoid arthritis |
| 001E98 |
M. J. Leandro [Royaume-Uni] ; G. Cambridge [Royaume-Uni] ; J. C. Edwards [Royaume-Uni] ; M. R. Ehrenstein [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients |
| 001F03 |
A. Rahman [Royaume-Uni] ; S. J. Bowman [Royaume-Uni] ; I. P. Giles [Royaume-Uni] ; Y. Ioannou [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | Annus mirabilis—a guide to the 6th European Lupus Meeting, 3–5 March 2005 |
| 001F06 |
Martin L. Read [Royaume-Uni] ; Surjeet Singh [Royaume-Uni] ; Zubair Ahmed ; Mark Stevenson [Royaume-Uni] ; Simon S. Briggs [Royaume-Uni] ; David Oupicky [États-Unis] ; Lee B. Barrett [États-Unis] ; Rachel Spice ; Mark Kendall [Royaume-Uni] ; Martin Berry ; Jon A. Preece [Royaume-Uni] ; Ann Logan ; Leonard W. Seymour [Royaume-Uni] | A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids |
| 001F12 |
R. Dinwiddie [Royaume-Uni] | Treatment of interstitial lung disease in children. |
| 001F22 |
Ben Ariff [Royaume-Uni] ; Andrew Zambanini [Royaume-Uni] ; Vamadeva Sarita [Royaume-Uni] ; Dean Barratt [Royaume-Uni] ; Yun Xu [Royaume-Uni] ; Peter Sever [Royaume-Uni] ; Nish Chaturvedi [Royaume-Uni] ; Alice Stanton [Royaume-Uni] ; Simon Thom [Royaume-Uni] ; Alun Hughes [Royaume-Uni] | P-273: Hemodynamic determinants of carotid artery structure in essential hypertension |
| 001F23 |
S. Kamath [Royaume-Uni] ; Ab Hassell [Royaume-Uni] | Management of inflammatory arthritis in the older person |
| 001F29 |
J. Prince Jeyadevan [États-Unis] ; Patrick G. Bray [États-Unis] ; James Chadwick [États-Unis] ; Amy E. Mercer [États-Unis] ; Aoife Byrne [États-Unis] ; Stephen A. Ward [États-Unis] ; B. Kevin Park [États-Unis] ; Dominic P. Williams [États-Unis] ; Rick Cosstick [États-Unis] ; Jill Davies [États-Unis] ; Adrian P. Higson [États-Unis] ; Ed Irving [États-Unis] ; Gary H. Posner [États-Unis] ; Paul M. O'Neill [États-Unis, Royaume-Uni] | Antimalarial and Antitumor Evaluation of Novel C-10 Non-Acetal Dimers of 10β-(2-Hydroxyethyl)deoxoartemisinin |
| 001F38 |
C. E. Lampropoulos [Royaume-Uni] ; S. Sangle [Royaume-Uni] ; P. Harrison [Royaume-Uni] ; G. R. V. Hughes [Royaume-Uni] ; D. P. D'Cruz [Royaume-Uni] | Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative |
| 001F42 |
Susan J. Brown [Royaume-Uni] ; Maggie E. Somerset [Royaume-Uni] ; Candy S. Mccabe [Royaume-Uni] ; Neil J. Mchugh [Royaume-Uni] | The impact of group education on participants' management of their disease in lupus and scleroderma |
| 001F54 |
P. D. Yesudian [Royaume-Uni] ; R. M. Azurdia [Royaume-Uni] | Scar sarcoidosis following tattooing of the lips treated with mepacrine |
| 001F59 |
Xiaohong Zhang [Royaume-Uni] ; Xuebin Dong [Royaume-Uni] ; Greta J. Sawyer [Royaume-Uni] ; Louise Collins [Royaume-Uni] ; John W. Fabre [Royaume-Uni] | Regional hydrodynamic gene delivery to the rat liver with physiological volumes of DNA solution |
| 001F60 |
A. R. Clewes [Royaume-Uni] ; J. K. Dawson [Royaume-Uni] | Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis |
| 001F87 |
Jonathan L. Vennerstrom [États-Unis] ; Sarah Arbe-Barnes [Royaume-Uni] ; Reto Brun [Suisse] ; Susan A. Charman [Australie] ; Francis C. K. Chiu [Australie] ; Jacques Chollet [Suisse] ; Yuxiang Dong [États-Unis] ; Arnulf Dorn [Suisse] ; Daniel Hunziker [Suisse] ; Hugues Matile [Suisse] ; Kylie Mcintosh [Australie] ; Maniyan Padmanilayam [États-Unis] ; Josefina Santo Tomas [Suisse] ; Christian Scheurer [Suisse] ; Bernard Scorneaux [Suisse] ; Yuanqing Tang [États-Unis] ; Heinrich Urwyler [Suisse] ; Sergio Wittlin [Suisse] ; William N. Charman [Australie] | Identification of an antimalarial synthetic trioxolane drug development candidate |
| 001F91 |
A. Samanta ; L. Goh [Royaume-Uni] ; A. Bawendi | Guidelines for the monitoring of hydroxychloroquine: reply |
| 001F99 |
A. N. Bennett [Royaume-Uni] ; S. R. Sangle [Royaume-Uni] ; G. R. V. Hughes [Royaume-Uni] ; D. P. D Ruz [Royaume-Uni] | Dermatomyositis developing in a Duchenne muscular dystrophy carrier |
| 002009 |
J. Ravindran ; N. Shenker ; A. K. Bhalla ; H. Lachmann [Royaume-Uni] ; P. Hawkins [Royaume-Uni] | Case report: response in proteinuria due to AA amyloidosis but not Felty’s syndrome in a patient with rheumatoid arthritis treated with TNF-α blockade |
| 002027 |
P. Jobanputra [Royaume-Uni] ; J. Wilson [Royaume-Uni] ; K. Douglas [Royaume-Uni] ; A. Burls [Royaume-Uni] | A survey of British rheumatologists’ DMARD preferences for rheumatoid arthritis |
| 002035 |
S. E. Reece [Royaume-Uni] ; A. Duncan [Royaume-Uni] ; S. A. West [Royaume-Uni] ; A. F. Read [Royaume-Uni] | Sex ratios in the rodent malaria parasite, Plasmodium chabaudi |
| 002039 |
Mohga Kamal Smith [Royaume-Uni] ; Sophia Tickell [Royaume-Uni] | The essential drugs concept is needed now more than ever |
| 002041 |
Paul M. O'Neill [Royaume-Uni] ; Amira Mukhtar [Royaume-Uni] ; Paul A. Stocks [Royaume-Uni] ; Laura E. Randle [Royaume-Uni] ; Stephen Hindley [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] ; Richard C. Storr [Royaume-Uni] ; Jamie F. Bickley [Royaume-Uni] ; Ian A. O'Neil [Royaume-Uni] ; James L. Maggs [Royaume-Uni] ; Ruth H. Hughes [Royaume-Uni] ; Peter A. Winstanley [Royaume-Uni] ; Patrick G. Bray [Royaume-Uni] ; B. Kevin Park [Royaume-Uni] | Isoquine and Related Amodiaquine Analogues: A New Generation of Improved 4-Aminoquinoline Antimalarials |
| 002043 |
Stephen D. Lawn [Royaume-Uni] ; Sanjeev Krishna [Royaume-Uni] ; Joseph N. Jarvis [Royaume-Uni] ; Thierry Joet [Royaume-Uni] ; Derek C. Macallan [Royaume-Uni] | Case reports: pernicious complications of benign tertian malaria |
| 002048 |
Martin L. Read [Royaume-Uni] ; K. Helen Bremner [Royaume-Uni] ; David Oupick [Royaume-Uni] ; Nicola K. Green [Royaume-Uni] ; Peter F. Searle [Royaume-Uni] ; Leonard W. Seymour [Royaume-Uni] | Vectors based on reducible polycations facilitate intracellular release of nucleic acids |
| 002054 |
Xiaohong Zhang [Royaume-Uni] ; Greta J. Sawyer [Royaume-Uni] ; Xuebin Dong [Royaume-Uni] ; Ying Qiu [Royaume-Uni] ; Louise Collins [Royaume-Uni] ; John W. Fabre [Royaume-Uni] | The in vivo use of chloroquine to promote non‐viral gene delivery to the liver via the portal vein and bile duct |
| 002064 |
W D Carroll [Royaume-Uni] ; R. Dhillon | Sildenafil as a treatment for pulmonary hypertension |
| 002068 |
D. Symmons [Royaume-Uni] | Reply |
| 002072 |
J. Kirwan [Royaume-Uni] | Principles of glucocorticoid therapy |
| 002081 |
K A Grindulis [Royaume-Uni] ; G. Bhatia [Royaume-Uni] ; R. Davis [Royaume-Uni] ; M. Sosin [Royaume-Uni] ; D. Connolly [Royaume-Uni] ; F. Khattak [Royaume-Uni] | Osteoarthritis and cardiovascular death |
| 002095 |
M. Gordon ; C. Buck ; R. Madhok [Royaume-Uni] | Inflammatory arthritis presenting as scrotal pain |
| 002106 |
O. Kayser [Allemagne] ; C. Olbrich [Allemagne] ; S. L. Croft [Royaume-Uni] ; A. F. Kiderlen [Allemagne] | Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs |
| 002110 |
N. Porter ; H. L. Beynon [Royaume-Uni] ; H. S. Randeva | Endocrine and reproductive manifestations of sarcoidosis |
| 002117 |
M. S. Lillicrap [Royaume-Uni] ; P. Merry [Royaume-Uni] | Cutaneous vasculitis associated with rofecoxib |
| 002124 |
S. L. Nuttall ; S. Heaton [Royaume-Uni] ; M. K. Piper [Royaume-Uni] ; U. Martin ; C. Gordon [Royaume-Uni] | Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidaemia |
| 002125 |
M. Lockshin [États-Unis] ; F. Tenedios [États-Unis] ; M. Petri [États-Unis] ; G. Mccarty [États-Unis] ; R. Forastiero [Argentine] ; S. Krilis [Australie] ; A. Tincani [Italie] ; D. Erkan [États-Unis] ; M A Khamashta [Royaume-Uni] ; Y. Shoenfeld [Israël] | Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report |
| 002127 |
N. H. Cox [Royaume-Uni] ; J. G. Palmer [Royaume-Uni] | Bowel‐associated dermatitis–arthritis syndrome associated with ileo‐anal pouch anastomosis, and treatment with mycophenolate mofetil |
| 002145 |
A. Casartelli [Italie] ; M. Bonato [Italie] ; P. Cristofori [Italie] ; F. Crivellente [Italie] ; G. Dal Negro [Italie] ; I. Masotto [Italie] ; C. Mutinelli [Italie] ; K. Valko [Royaume-Uni] ; V. Bonfante [Italie] | A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development |
| 002172 |
H. Chinoy [Royaume-Uni] ; F. Mckenna [Royaume-Uni] | Wegener's granulomatosis and rheumatoid arthritis overlap |
| 002176 |
Jenz Klocker [Royaume-Uni] ; Jamie Duckers [Royaume-Uni] ; Rhian Morse [Royaume-Uni] ; Abhaya Gupta [Royaume-Uni] ; Penny Owen [Royaume-Uni] | Ulcerative cuteanous sarcoidosis masquerading as metastatic carcinoma of the beast |
| 002183 |
M. M. U. Chowdhury [Royaume-Uni] ; E. J. Williams ; J. S. Morris ; B. J. M. Ferguson ; A. D. Mcgregor [Royaume-Uni] ; A. R. Hedges ; J. D. Stamatakis ; F. M. Pope [Royaume-Uni] | Severe panniculitis caused by homozygous ZZ α1‐antitrypsin deficiency treated successfully with human purified enzyme (Prolastin®) |
| 002186 |
P. Banerjee [Royaume-Uni] ; C. A. Holden [Royaume-Uni] | Sarcoidosis presenting with pyoderma gangrenosum |
| 002196 |
Roopa Prasad [Royaume-Uni] ; Malcolm De Silva [Royaume-Uni] | Osteoporosis with Underlying Connective Tissue Disease |
| 002199 |
Anita Verma [Royaume-Uni] ; Jim J. Wade [Royaume-Uni] | Non-viral infections of the liver |
| 002205 |
Christopher M. Ward [Royaume-Uni] ; Michal Pechar ; David Oupicky [Royaume-Uni] ; Karel Ulbrich ; Leonard W. Seymour [Royaume-Uni] | Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo |
| 002211 |
H. S. Randeva [Royaume-Uni] ; R. Davison [Royaume-Uni] ; V. Chamoun [Royaume-Uni] ; P. M. G. Bouloux [Royaume-Uni] | Isolated neurosarcoidosis—a diagnostic enigma |
| 002219 |
R. Dinwiddie [Royaume-Uni] ; N. Sharief [Royaume-Uni] ; O. Crawford [Royaume-Uni] | Idiopathic interstitial pneumonitis in children: A national survey in the United Kingdom and Ireland |
| 002245 |
R. U. Sidwell [Royaume-Uni] ; M. A. A. Ibrahim [Royaume-Uni] ; C. B. Bunker [Royaume-Uni] | A case of common variable immunodeficiency presenting with furunculosis |
| 002257 |
David A. Warrell [Royaume-Uni] | To search and Studdy out the secrett of Tropical Diseases by way of Experiment |
| 002259 |
Guillermo Ruiz-Irastorza [Royaume-Uni] ; Munther A. Khamashta [Royaume-Uni] ; Gabriella Castellino [Royaume-Uni] ; Graham Rv Hughes [Royaume-Uni] | Systemic lupus erythematosus |
| 002261 |
Colin W. Wright [Royaume-Uni] ; Jonathan Addae-Kyereme [Royaume-Uni, Ghana] ; Anthony G. Breen [Royaume-Uni] ; John E. Brown [Royaume-Uni] ; Marlene F. Cox [Royaume-Uni, Guyana] ; Simon L. Croft [Royaume-Uni] ; Yaman Gökçek [Royaume-Uni] ; Howard Kendrick [Royaume-Uni] ; Roger M. Phillips [Royaume-Uni] ; Pamela L. Pollet [Royaume-Uni] | Synthesis and Evaluation of Cryptolepine Analogues for Their Potential as New Antimalarial Agents |
| 002270 |
Colin W. Pouton [Royaume-Uni] ; Leonard W. Seymour [Royaume-Uni] | Key issues in non-viral gene delivery |
| 002278 |
Raaj K. Praseedom [Royaume-Uni] ; Keith D. Mcneil ; Christopher Je Watson [Royaume-Uni] ; Graeme J. Alexander [Royaume-Uni] ; Roy Y. Calne [Royaume-Uni] ; John Wallwork ; Peter J. Friend [Royaume-Uni] | Combined transplantation of the heart, lung, and liver |
| 002288 |
P. J. Jost [Royaume-Uni, Allemagne] ; R. P. Harbottle [Royaume-Uni] ; A. Knight [Royaume-Uni] ; A. D. Miller [Royaume-Uni] ; C. Coutelle [Royaume-Uni] ; H. Schneider [Royaume-Uni, Allemagne] | A novel peptide, THALWHT, for the targeting of human airway epithelia |
| 002292 |
T. C. Ling [Royaume-Uni] ; G. Parkin [Royaume-Uni] ; J. Islam [Royaume-Uni] ; D. C. Seukeran [Royaume-Uni] ; W. J. Cunliffe [Royaume-Uni] | What is the cumulative effect of long‐term, low‐dose isotretinoin on the development of DISH? |
| 002325 |
G J Gibson [Royaume-Uni] | Sarcoidosis: old and new treatments |
| 002327 |
D Geraint James [Royaume-Uni] | Sarcoidosis 2001 |
| 002331 |
S. J. Bowman ; S. Pillemer ; R. Jonsson ; K. Asmussen ; C. Vitali ; R. Manthorpe [Suède] ; N. Sutcliffe [Royaume-Uni] | Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK |
| 002339 |
W. M. Porter [Royaume-Uni] ; H. Du P. Menagé [Royaume-Uni] ; G. Philip [Royaume-Uni] ; C. B. Bunker [Royaume-Uni] | Porokeratosis of the penis |
| 002342 |
S. M. Cooper [Royaume-Uni] ; S. George [Royaume-Uni] | Photosensitivity reaction associated with use of the combined oral contraceptive |
| 002356 |
Stephen Watt-Smith [Royaume-Uni] ; Kuljeet Mehta [Royaume-Uni] ; Crispian Scully [Royaume-Uni] | Mefloquine-induced trigeminal sensory neuropathy |
| 002358 |
Janice Taverne [Royaume-Uni] | Malaria in the New World and elsewhere |
| 002376 |
R. U. Sidwell [Royaume-Uni] ; N. Francis [Royaume-Uni] ; C. B. Bunker [Royaume-Uni] | Hormonal influence on reticular erythematous mucinosis |
| 002377 |
S. Copley [Royaume-Uni] ; S. Padley [Royaume-Uni] | High-resolution CT of paediatric lung disease |
| 002387 |
Emily S. Scott [Royaume-Uni] ; John W. Wiseman [Royaume-Uni] ; Martin J. Evans [Royaume-Uni] ; William H. Colledge [Royaume-Uni] | Enhanced gene delivery to human airway epithelial cells using an integrin‐targeting lipoplex |
| 002391 |
J. Robert Espina [États-Unis] ; John P. Shockcor [Royaume-Uni] ; William J. Herron [États-Unis] ; Bruce D. Car [États-Unis] ; Nancy R. Contel [États-Unis] ; Paul J. Ciaccio [États-Unis] ; John C. Lindon [Royaume-Uni] ; Elaine Holmes [Royaume-Uni] ; Jeremy K. Nicholson [Royaume-Uni] | Detection of in vivo biomarkers of phospholipidosis using NMR‐based metabonomic approaches |
| 002393 |
S. J. R. Allan [Royaume-Uni] ; M. J. Tidman [Royaume-Uni] | Dermatology dressings: an incendiary potential |
| 002394 |
H. S. Pandha ; Peter Mortimer (dermatologue) [Royaume-Uni] ; B. Souberbeille ; P. Mccoubrie ; M. E. R. O'Brien | Cutaneous toxicity after intradermal vaccination with Mycobacterium vaccae against lung cancer and malignant mesothelioma |
| 002398 |
H. A. Shehata [Royaume-Uni] ; C. Nelson-Piercy [Royaume-Uni] | Connective tissue and skin disorders in pregnancy |
| 002399 |
A. V. Evans [Royaume-Uni] ; A. Darvay [Royaume-Uni] ; I. H. Jenkins [Royaume-Uni] ; R. Russell-Jones [Royaume-Uni] | Compartment syndrome following an insect bite |
| 002406 |
L. Pang [Royaume-Uni] | COX-2 expression in asthmatic airways: the story so far |
| 002421 |
Sheetal Patel [Royaume-Uni] ; Xiaohong Zhang [Royaume-Uni] ; Louise Collins [Royaume-Uni] ; John W. Fabre [Royaume-Uni] | A small, synthetic peptide for gene delivery via the serpin–enzyme complex receptor |
| 002422 |
Xiaohong Zhang [Royaume-Uni] ; Louise Collins [Royaume-Uni] ; John W. Fabre [Royaume-Uni] | A powerful cooperative interaction between a fusogenic peptide and lipofectamine for the enhancement of receptor‐targeted, non‐viral gene delivery via integrin receptors |
| 002434 |
R. Dinwiddie [Royaume-Uni] | Case 3: Assessment: systemic illness and the chest. |
| 002435 |
Ajay K. Agrawal [Royaume-Uni] ; C. M Gupta [Inde] | Tuftsin-bearing liposomes in treatment of macrophage-based infections |
| 002437 |
P. Chowdhury [Royaume-Uni] ; C. M. Andrews [Royaume-Uni] | The influence of sequential blood sampling in untreated rats on cellular blood parameters |
| 002438 |
John N. Haselden [Royaume-Uni] ; Francis K. Lam [Royaume-Uni] ; Andrew W. Nicholls [Royaume-Uni] ; Catherine J. Waterfield [Royaume-Uni] ; Jeremy K. Nicholson [Royaume-Uni] | The identification of a marker of phospholipidosis using biofluid 1H NMR spectroscopy |
| 002439 |
S. J Cheesman [Royaume-Uni] | The Topoisomerases of Protozoan Parasites |
| 002443 |
M. D. Brown [Royaume-Uni] ; A. Sch Tzlein [Royaume-Uni] ; A. Brownlie [Royaume-Uni] ; V. Jack [Royaume-Uni] ; W. Wang [Royaume-Uni] ; L. Tetley [Royaume-Uni] ; A. I. Gray [Royaume-Uni] ; I. F. Uchegbu [Royaume-Uni] | Preliminary Characterization of Novel Amino Acid Based Polymeric Vesicles as Gene and Drug Delivery Agents |
| 002444 |
Nicholas A. Jones [Royaume-Uni] ; I. R. C Hill [Royaume-Uni] ; Snjezana Stolnik [Royaume-Uni] ; Fabio Bignotti [Italie] ; Stanley S. Davis [Royaume-Uni] ; Martin C. Garnett [Royaume-Uni] | Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer–DNA complexes for gene delivery |
| 002447 |
Ian N. Bruce [Royaume-Uni] ; Dafna D. Gladman ; Murray B. Urowitz | PREMATURE ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS |
| 002467 |
Y. Kubota [Japon] ; S. Takahashi [Japon] ; I. Takahashi [Japon] ; G. Patrick [Royaume-Uni] | Different cytotoxic response to gadolinium between mouse and rat alveolar macrophages |
| 002480 |
R. Dinwiddie [Royaume-Uni] | The lung in multi-system disease |
| 002507 |
D. J. Clutterbuck ; J. Watson ; A. De Ruiter ; T. Godfrey [Royaume-Uni] ; C. Bradbeer | Presence of HIV infection in patients diagnosed with systemic lupus erythematosus |
| 002511 |
I. Ahmed [Royaume-Uni] ; R. Charles-Holmes [Royaume-Uni] | Phytophotodermatitis mimicking superficial lymphangitis |
| 002512 |
M. Eddleston [Royaume-Uni] | Patterns and problems of deliberate self‐poisoning in the developing world |
| 002515 |
F. Antony [Royaume-Uni] ; A. M. Layton [Royaume-Uni] | Nabumetone‐associated pseudoporphyria |
| 002520 |
S. M. Sultan [Royaume-Uni] ; Y. Ioannou [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long‐term review |
| 002542 |
P J Maddison [Royaume-Uni] ; C. Thorpe ; J R C. Seale ; W. Ahmed ; G S Whiteley [Royaume-Uni] | Grand Rounds from International Lupus Centres `Catastrophic' antiphospholipid syndrome |
| 002544 |
Lp Robertson [Royaume-Uni] ; Mg Davies [Royaume-Uni] ; P. Hickling | Generalized morphoea in a patient with Felty’s syndrome |
| 002551 |
Dipen S. Shah [Royaume-Uni] ; T. Sakthivel [Royaume-Uni] ; Istvan Toth [Royaume-Uni] ; Alexander T. Florence [Royaume-Uni] ; Andy F. Wilderspin [Royaume-Uni] | DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers |
| 002553 |
S. J. Morton [Royaume-Uni] ; R. J. Powell [Royaume-Uni] | Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma |
| 002556 |
T. S. Harrison [Royaume-Uni] | Cryptococcus neoformans and Cryptococcosis |
| 002558 |
D. M. Koh [Royaume-Uni] ; D. M. Hansell [Royaume-Uni] | Computed Tomography of Diffuse Interstitial Lung Disease in Children |
| 002562 |
M. Conron [Royaume-Uni] ; C. Young [Royaume-Uni] ; H. L. C. Beynon [Royaume-Uni] | Calcium metabolism in sarcoidosis and its clinical implications |
| 002569 |
Y. I. Patel ; A. St John ; N. J. Mchugh [Royaume-Uni] | Antiphospholipid syndrome with proliferative vasculopathy and bowel infarction |
| 002583 |
F. Antony [Royaume-Uni] ; A. M. Layton [Royaume-Uni] | A case of cutaneous acral sarcoidosis with response to allopurinol |
| 002591 |
N. Fergie [Royaume-Uni] ; N. S. Jones [Royaume-Uni] ; M. F. Havlat [Royaume-Uni] | The nasal manifestations of sarcoidosis: a review and report of eight cases |
| 002613 |
Ravinder Maini [Royaume-Uni] ; E William St Clair [États-Unis] ; Ferdinand Breedveld [Pays-Bas] ; Daniel Furst [États-Unis] ; Joachim Kalden [Allemagne] ; Michael Weisman [États-Unis] ; Josef Smolen [Autriche] ; Paul Emery [Royaume-Uni] ; Gregory Harriman [États-Unis] ; Marc Feldmann [Royaume-Uni] ; Peter Lipsky [États-Unis] | Infliximab (chimeric anti-tumour necrosis factor monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial |
| 002631 |
Anne Kobza Black [Royaume-Uni] | Urticarial vasculitis |
| 002642 |
Charles J. Woodrow [Royaume-Uni] ; Isabela Riberio [Royaume-Uni] ; Sanjeev Krishna [Royaume-Uni] | Recent developments in the management of malaria |
| 002647 |
A. Sinha ; N. Dixon ; M. M. O'Sullivan ; J. M. Sowden [Royaume-Uni] | Porphyria cutanea tarda in a patient with systemic lupus erythematosus |
| 002676 |
P. R. Smith ; D. D'Cruz ; M. J. Raftery ; S. M. Dodd ; M. Helbert [Royaume-Uni] ; C. J. Skinner | Drug-induced lupus nephritis in HIV infection |
| 002680 |
Tamás Henics [Hongrie, Autriche] ; Denys N. Wheatley [Royaume-Uni] | Cytoplasmic vacuolation, adaptation and cell death: A view on new perspectives and features |
| 002687 |
J. P. Zajicek ; N. J. Scolding ; O. Foster ; M. Rovaris ; J. Evanson ; I. F. Moseley ; J. W. Scadding ; E. J. Thompson ; V. Chamoun ; D. H. Miller ; W. I. Mcdonald ; D. Mitchell [Royaume-Uni] | Central nervous system sarcoidosis—diagnosis and management |
| 002689 |
Rabindranath Nambi [Royaume-Uni] ; .. Dd [Royaume-Uni] ; Sriramulu Tharakaram [Royaume-Uni] | Carcinoma erysipeloides as a presenting feature of breast carcinoma |
| 002693 |
Millard [Royaume-Uni] ; Smith [Royaume-Uni] ; Black [Royaume-Uni] ; Barker [Royaume-Uni] | Bullous pemphigoid developing during systemic therapy with chloroquine |
| 002694 |
Jill P. Buyon [États-Unis] ; Kenneth C. Kalunian [États-Unis] ; Rosalind Ramsey-Goldman [États-Unis] ; Michelle A. Petri ; Michael D. Lockshin [États-Unis] ; Guillermo Ruiz-Irastorza ; Munther Khamashta [Royaume-Uni] | Assessing disease activity in SLE patients during pregnancy |
| 002703 |
S. M. Sultan [Royaume-Uni] ; Y. Ioannou [Royaume-Uni] ; D. A. Isenberg [Royaume-Uni] | A review of gastrointestinal manifestations of systemic lupus erythematosus |
| 002730 |
Charles R. J. C. Newton [Royaume-Uni] ; Sanjeev Krishna [Royaume-Uni] | Severe Falciparum Malaria in Children |
| 002732 |
G. Devereux [Royaume-Uni] ; M. J. Evans [Royaume-Uni] ; K. M. Kerr [Royaume-Uni] ; J. S. Legge [Royaume-Uni] | Pulmonary veno-occlusive disease complicating Felty's syndrome |
| 002733 |
S. Pukrittayakamee [Thaïlande] ; A. Chantra [Thaïlande] ; S. Vanijanonta [Thaïlande] ; N. J. White [Thaïlande, Royaume-Uni] | Pulmonary oedema in vivax malaria |
| 002736 |
Colin W. Pouton [Royaume-Uni] ; Paul Lucas [Royaume-Uni] ; Beverley J. Thomas [Royaume-Uni] ; Aimalohi N. Uduehi [Royaume-Uni] ; David A. Milroy [Royaume-Uni] ; Stephen H. Moss [Royaume-Uni] | Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids |
| 002741 |
R. Madhok [Royaume-Uni] ; N. Maiden [Royaume-Uni] ; H. Capell [Royaume-Uni] | Non-steroidal anti-inflammatory therapy for asthma |
| 002742 |
Om Kon [Royaume-Uni] ; Ds Robinson [Royaume-Uni] | Non-steroidal anti-inflammatory therapy for asthma |
| 002743 |
Ab Kay [Royaume-Uni] ; Nc Barnes [Royaume-Uni] | Non-steroidal anti-inflammatory therapy for asthma |
| 002745 |
Kennedy R. Lees [Royaume-Uni] | Multifactorial approach to stroke investigation and prevention |
| 002752 |
Colin W. Pouton [Royaume-Uni] ; Leonard W. Seymour [Royaume-Uni] | Key issues in non-viral gene delivery |
| 002755 |
A. H Fell [États-Unis, Royaume-Uni] ; N. C Smith [Australie] | Immunity to Asexual Blood Stages of Plasmodium : Is Resistance to Acute Malaria Adaptive or Innate? |
| 002768 |
Je Brockbank [Royaume-Uni] ; Ml Snaith [Royaume-Uni] | Connective tissue diseases in later life |
| 002779 |
Patrick G. Bray [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] | A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum |
| 002787 |
A G Nicholson ; H. Kim [Corée du Sud] ; B. Corrin ; A. Bush [Royaume-Uni] ; R M Du Bois [Royaume-Uni] ; M. Rosenthal [Royaume-Uni] ; M N Sheppard | The value of classifying interstitial pneumonitis in childhood according to defined histological patterns |
| 002811 |
A. Mcentegart [Royaume-Uni] ; R. D. Sturrock [Royaume-Uni] | Managing Heart Failure in the Patient with Chronic Joint Disease |
| 002812 |
I. B. Boehm [États-Unis] ; G. A. Boehm [Royaume-Uni] ; R. Bauer [États-Unis] | Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms |
| 002835 |
Farrell ; Moss [Royaume-Uni] ; Costello ; Fearfield ; Woodrow ; Bunker | Benign cutaneous Degos' disease |
| 002849 |
K. Barnes [Royaume-Uni] ; C. Brown [Royaume-Uni] ; A. J. Turner [Royaume-Uni] | Endothelin-converting enzyme : Ultrastructural localization and its recycling from the cell surface |
| 002878 |
Melissa Wickremasinghe [Royaume-Uni] ; Jon S. Friedland [Royaume-Uni] | Mycobacterium tuberculosis stimulates transcription-dependent chemokine secretion from human respiratory epithelial cells |
| 002890 |
Jill Turner [Royaume-Uni] | For WHO or for whom? |
| 002894 |
Rodrigo Salinas [Royaume-Uni] ; Kameshwar Prasad [Royaume-Uni] ; Paul Garner [Royaume-Uni] | Chile, India: evidence-based tropical medicine |
| 002910 |
Brian J. Kilbey [Royaume-Uni] | The DNA Replisome of the Malaria Parasite: Progress Towards a Useful Drug Target |
| 002922 |
Ian S. Blagbrough [Royaume-Uni] ; Simon Carrington [Royaume-Uni] ; Andrew J. Geall [Royaume-Uni] | Polyamines and Polyamine Amides as Potent Selective Receptor Probes, Novel Therapeutic Lead Compounds and Synthetic Vectors in Gene Therapy |
| 002924 |
G. Robins [Royaume-Uni] ; P. M. Farr [Royaume-Uni] | Pain relief with Emla of ulcerating lesions in mycosis fungoides |
| 002928 |
Anne Livingstone [Royaume-Uni] ; Robert J. Mairs [Royaume-Uni] | N-myc amplification and its relationship to experimental therapy |
| 002978 |
Neil Rayment [Royaume-Uni] ; Robert F. Miller [Royaume-Uni] ; Nabeel Ali [Royaume-Uni] ; Michael H. Binks [Royaume-Uni] ; David R. Katz [Royaume-Uni] | Synthesis of Tumor Necrosis Factor-α mRNA in Bronchoalveolar Lavage Cells from Human Immunodeficiency Virus-Infected Persons with Pneumocystis carinii Pneumonia |
| 002985 |
Hgm Shetty [Royaume-Uni] ; Pa Routledge [Royaume-Uni] | Prevention and treatment of venous thromboembolism in the elderly |
| 002992 |
Stuart Dollow [Royaume-Uni] | Neurological sequelae of cerebral malaria |
| 002993 |
R. Lee Kennedy [Royaume-Uni] ; Alexandram. Burton ; Robertf. Harrison ; Michaelh. Andreae [Royaume-Uni] | Neural networks and early diagnosis of myocardial infarction |
| 002996 |
Rh Behrens [Kenya, Royaume-Uni] ; Dj Bradley [Kenya] ; Rw Snow [Kenya] ; K. Marsh [Kenya] | Impact of UK malaria prophylaxis policy on imported malaria |
| 002A00 |
Alec Bonington [Royaume-Uni] ; Robert N. Davidson [Royaume-Uni] ; Peter A. Winstanley [Royaume-Uni] ; Geoffrey Pasvol [Royaume-Uni] | Fatal quinine cardiotoxicity in the treatment of falciparum malaria |
| 002A01 |
Delia B. Bethell [Viêt Nam] ; Pham Tung Phuong [Viêt Nam] ; Cao Xuan Thanh Phuong [Viêt Nam] ; François Nosten [Thaïlande] ; Deborah Waller [Viêt Nam] ; Timothy M. E. Davis [Royaume-Uni] ; Nicholas P. J. Day [Viêt Nam] ; Jane Crawley [Royaume-Uni] ; David Brewster [Gambie] ; Sasithon Pukrittayakamee [Thaïlande] ; Nicholas J. White [Viêt Nam] | Electrocardiographic monitoring in severe falciparum malaria |
| 002A06 |
Okezie I. Aruoma [Royaume-Uni] | Characterization of drugs as antioxidant prophylactics |
| 002A07 |
C. G. Missouris [Royaume-Uni] ; P. E. Hart [Royaume-Uni] ; D. R. J. Singer [Royaume-Uni] ; D. R. Redwood [Royaume-Uni] | Bilateral ostial coronary artery disease due to radiotherapy |
| 002A47 |
Andrew Bush [Royaume-Uni] | Diagnosis of interstitial lung disease |
| 002A48 |
T. W. Beer [Royaume-Uni] ; D. C. Rowlands [Royaume-Uni] ; J. Crocker [Royaume-Uni] | Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours. |
| 002A52 |
D. A. Spencer [Royaume-Uni] ; H. M. Alton [Royaume-Uni] ; F. Raafat [Royaume-Uni] ; P. H. Weller [Royaume-Uni] | Combined percutaneous lung biopsy and high‐resolution computed tomography in the diagnosis and management of lung disease in children |
| 002A72 |
L M Andersson [Royaume-Uni] ; M J Warburton | Intracellular degradation of type I collagen and fibronectin in human lung fibroblasts: evidence against degradation in pre-lysosomal compartments. |
| 002A88 |
Robert Booy [Royaume-Uni] ; Michael Pearce [Indonésie] ; John Sheridan [Australie] ; Wendy Holmes [Australie] | Outbreak of group C meningococcal disease in Australian Aboriginal children |
| 002A90 |
Sheena Mitchell [Royaume-Uni] | Neuropathies |
| 002A91 |
David Hilton-Jones [Royaume-Uni] | Myopathies |
| 002A93 |
J. A. Dodge [Royaume-Uni] | Male fertility in cystic fibrosis |
| 002A98 |
L. Monica [Royaume-Uni] ; B. Andersson [Royaume-Uni] ; Michael J. Warburton [Royaume-Uni] | Intracellular degradation of type I collagen and fibronectin in human lung fibroblasts: evidence against degradation in pre-lysosomal compartments |
| 002B00 |
J. B. Buick [Royaume-Uni] ; R. C. Lowry [Royaume-Uni] ; M. Riley [Royaume-Uni] | Idiopathic pulmonary haemosiderosis (IPH) |
| 002B16 |
Thomas Brüssel [Allemagne] ; Hugo Van Aken ; D. W. L. Davies [Allemagne] ; R. E. Collis [Royaume-Uni] ; W. Aveling [Royaume-Uni] | Combined spinal-epidural or standard epidural analgesia in labour |
| 002B23 |
L. B. Tucker [États-Unis] ; S. Menon [Royaume-Uni] ; J. G. Schaller [États-Unis] ; D. A. Isenberg [Royaume-Uni] | ADULT- AND CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: A COMPARISON OF ONSET, CLINICAL FEATURES, SEROLOGY, AND OUTCOME |
| 002B37 |
S. R. Mcmechan [Royaume-Uni] ; B. M. Mcclements [Royaume-Uni] ; P. P. Mckeown [Royaume-Uni] ; S. W. Webb [Royaume-Uni] ; A. A. Adgey [Royaume-Uni] | Systemic lupus erythematosus presenting as effuso-constrictive pericarditis. |
| 002B42 |
Caroline Gordon [Royaume-Uni] | Rheumatic diseases in pregnancy |
| 002B51 |
J. R. Hughes ; C. C. Erhardt ; M. Clement [Royaume-Uni] | Neutrophilic dermatosis in association with rheumatoid arthritis |
| 002B63 |
Michael J. Davies [Royaume-Uni] ; Saify S. Arsiwala [Royaume-Uni] ; Hillary M. Moore [Royaume-Uni] ; Steven Kerr [Royaume-Uni] ; Andrezej W. Sosnowski [Royaume-Uni] ; Richard K. Firmin [Royaume-Uni] | Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism |
| 002B71 |
Jacqueline Guy [Royaume-Uni] ; Dubravka Drabek [Royaume-Uni] ; Michael Antoniou [Royaume-Uni] | Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy |
| 002B75 |
J M Hill [Royaume-Uni] ; A E Tattersfield [Royaume-Uni] | Corticosteroid sparing agents in asthma. |
| 002B83 |
P. C. Rubin [Royaume-Uni] | Antimalarial drugs in pregnancy |
| 002B90 |
Eric H. Karran [Royaume-Uni] ; Kathryn Dodgson [Royaume-Uni] ; Sonia J. Harris [Royaume-Uni] ; Roger E. Markwell [Royaume-Uni] ; Gregory P. Harper [Royaume-Uni] | A simple in vivo model of collagen degradation using collagen-gelled cotton buds: The effects of collagenase inhibitors and other agents |
| 002B92 |
Julian Gunn [Royaume-Uni] ; Cathy M. Holt [Royaume-Uni] ; Lynda Shepherd [Royaume-Uni] ; Sheila E. Francis [Royaume-Uni] ; Geoffrey H. Smith [Royaume-Uni] ; David C. Cumberland [Royaume-Uni] | 793-4 Local Delivery of C-myb Antisense attenuates Neo-Intimal Thickening in a Porcine Model of Coronary Angioplasty |
| 002C21 |
A. Tyndall [Suisse, Royaume-Uni] ; W. Jelk [Suisse, Royaume-Uni] ; H. H. Hirsch [Suisse, Royaume-Uni] | Parvovirus B19 and erosive polyarthritis |
| 002C23 |
Jim Egan [Royaume-Uni] ; James Stewart [Royaume-Uni] ; Nizar Yonan [Royaume-Uni] ; John Arrand [Royaume-Uni] ; Ashley Woodcock [Royaume-Uni] ; Dietrich Peest [Allemagne] ; Helmuth Deicher [Allemagne] | Non-Hodgkin lymphoma in heart/lung transplant recipients |
| 002C58 |
Riad A. L. Bayoumi [Émirats arabes unis] ; Hamza A. Babiker [Royaume-Uni] ; David E. Arnot [Royaume-Uni] | Uptake and efflux of chloroquine by chloroquine-resistant Plasmodium falciparum clones recently isolated in Africa |
| 002C60 |
N. J. L. Gittoes [Royaume-Uni] | Therapeutic progress I: Current treatment of rheumatoid arthritis |
| 002C61 |
S. C. F. Blackburn [Royaume-Uni] ; R. Ellis [Royaume-Uni] ; C. F. George [Royaume-Uni] ; J. R. Kirwan [Royaume-Uni] | The impact and treatment of arthritis in general practice |
| 002C69 |
Patricia J. Evans [Royaume-Uni] ; Dola Akanmu [Royaume-Uni] ; Barry Halliwell [Royaume-Uni] | Promotion of oxidative damage to arachidonic acid and α 1-antiproteinase by anti-inflammatory drugs in the presence of the haem proteins myoglobin and cytochrome C |
| 002C84 |
N. Sharief [Royaume-Uni] ; O. F. Crawford [Royaume-Uni] ; R. Dinwiddie [Royaume-Uni] | Fibrosing alveolitis and desquamative interstitial pneumonitis |
| 002C87 |
Bridget T. Hill [Royaume-Uni] ; Louise K. Hosking [France] | Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance |
| 002C99 |
S. Johnson [Royaume-Uni] ; A. J. Knox [Royaume-Uni] | Arthropathy in cystic fibrosis |
| 002D15 |
R. Alan Wilson [Royaume-Uni] ; Alan Sher [États-Unis] | Vaccines against schistosomes: an alternative view |
| 002D18 |
R. M. Ekong [Royaume-Uni] ; K. J. H. Robson ; D. A. Baker ; D. C. Warhurst | Transcripts of the multidrug resistance genes in chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum |
| 002D21 |
David Emerton [Royaume-Uni] | The management of malaria in a district hospital: what drugs?—A reply |
| 002D22 |
C P Conlon [Royaume-Uni] | The immunocompromised traveller |
| 002D24 |
G. G. Colle [Royaume-Uni] ; G. C. Hanson | THE MANAGEMENT OF ACUTE POISONING |
| 002D33 |
Neil Mm Buchanan [Royaume-Uni] ; Munther Khamashta [Royaume-Uni] ; Sian Kerslake [Royaume-Uni] ; Beverley J Hunt [Royaume-Uni] ; Graham Rv Hughes [Royaume-Uni] | Practical management of pregnancy in systemic lupus erythematosus |
| 002D39 |
R H Behrens [Royaume-Uni] ; C F Curtis [Royaume-Uni] | Malaria in travellers: Epidemiology and prevention |
| 002D67 |
S. Menon ; M. L. Snaith [Royaume-Uni] ; D. A. Isenberg | The Association of Malignancy with SLE: An Analysis of 150 Patients Long-Term Review |
| 002D70 |
A. A. Borg [Royaume-Uni] ; C. Wynn-Jones [Royaume-Uni] ; P. T. Dawes [Royaume-Uni] | Synovial sarcoma manifesting as a single joint flare in rheumatoid arthritis |
| 002D79 |
P. S. Shetty [Inde, Royaume-Uni] ; N. Shetty [Inde] | Parasitic infection and chronic energy deficiency in adults |
| 002D84 |
S. Tariq [Royaume-Uni] ; S. M. Tariq [Royaume-Uni] | Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent? |
| 002D94 |
Edward J. Wawrzynczak [Royaume-Uni] ; Elaine J. Derbyshire [Royaume-Uni] | Immunotoxins to human small-cell lung cancer |
| 002D96 |
J. R. Mcpeake [Royaume-Uni] ; W. J. R. Hirst [Royaume-Uni] ; A. M. Brind [Royaume-Uni] ; Roger Williams [Royaume-Uni] | Hepatitis A causing a second episode of virus–associated haemophagoeytic lymphohistiocytosis in a patient with Still's disease |
| 002E22 |
B. Middleton [Royaume-Uni] ; A. Middleton | Cyclic AMP stimulates the synthesis and function of the low-density lipoprotein receptor in human vascular smooth-muscle cells and fibroblasts. |
| 002E23 |
C. Cardona [Royaume-Uni] ; N M Bleehen ; J G Reeve | Characterization of ligand binding and processing by gastrin-releasing peptide receptors in a small-cell lung cancer cell line. |
| 002E24 |
E. A. Kay [Royaume-Uni] ; T. Pullar | VARIATIONS AMONG RHEUMATOLOGISTS IN PRESCRIBING AND MONITORING OF DISEASE MODIFYING ANTIRHEUMATOID DRUGS |
| 002E25 |
M. Ahmed [Royaume-Uni] ; K. P. W. J. Mcadam [Royaume-Uni] ; A. W. Sturm [Royaume-Uni] ; R. Hussain [Royaume-Uni, Pakistan] | Systemic Manifestations of Invasive Amebiasis |
| 002E48 |
G. C. Cook [Royaume-Uni] | Use of antiprotozoan and anthelmintic drugs during pregnancy: Side-effects and contra-indications |
| 002E50 |
E. A. Lock [Royaume-Uni] ; E. S. Harpur [Royaume-Uni] | Toxicology of Sensory Systems: A Perspective |
| 002E53 |
Anthony C. Harrison [Royaume-Uni] ; Neil R. Kitteringham [Royaume-Uni] ; Janet B. Clarke [Royaume-Uni] ; B. Kevin Park [Royaume-Uni] | The mechanism of bioactivation and antigen formation of amodiaquine in the rat |
| 002E68 |
G. C. Cook [Royaume-Uni] | Malaria: an underdiagnosed and often neglected medical emergency |
| 002E69 |
Bruce Middleton [Royaume-Uni] | Lysosome inhibitors enhance the ability of cyclic AMP-elevating agents to induce the LDL receptor in human vascular smooth muscle cells |
| 002E70 |
D. Geraint James [Royaume-Uni] | Lupus Pernio |
| 002E85 |
Howard Bird [Royaume-Uni] | Author's reply |
| 002E94 |
D A Spencer [Royaume-Uni] ; J F Price | A case of fibrosing alveolitis in childhood. |
| 002E97 |
Ronald A. Asherson [Royaume-Uni] ; David D'Cruz [Royaume-Uni] ; Catherine J. M. Stephens [Royaume-Uni] ; Phillip H. Mckee [Royaume-Uni] ; G. R. V. Hughes [Royaume-Uni] | Urticarial vasculitis in a connective tissue disease clinic: Patterns, presentations, and treatment |
| 002F09 |
Christinea. Facer [Royaume-Uni] ; D. Rouse [Royaume-Uni] | Spontaneous splenic rupture due to Plasmodium ovale malaria |
| 002F21 |
David Hilton-Jones [Royaume-Uni] | Myopathies |
| 002F33 |
A. Samanta [Royaume-Uni] ; S. Roy [Royaume-Uni] ; K. L. Woods [Royaume-Uni] | Gold therapy in rheumatoid arthritis |
| 002F43 |
A. E. Wakefield [Royaume-Uni] ; L. Guiver [Royaume-Uni] ; R. F. Miller [Royaume-Uni] ; J. M. Hopkin [Royaume-Uni] | DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia |
| 002F45 |
A. C. Magee [Royaume-Uni] ; F. J. Stewart [Royaume-Uni] ; J. Nevin [Royaume-Uni] ; N. C. Nevin [Royaume-Uni] ; J. C. Dornan [Royaume-Uni] ; M. J. Armstrong [Royaume-Uni] ; J. G. Thornton [Royaume-Uni] | Chorionic villus sampling for Down's syndrome |
| 002F53 |
G. C. Cook [Royaume-Uni] | Tropical medicine. |
| 002F54 |
R A Asherson [Royaume-Uni] ; H. Angus [Royaume-Uni] ; J A Mathews [Royaume-Uni] ; O. Meyers [Royaume-Uni] ; G R Hughes [Royaume-Uni] | The progressive systemic sclerosis/systemic lupus overlap: an unusual clinical progression. |
| 002F60 |
R. A. Asherson [Royaume-Uni] ; R. Cervera [Royaume-Uni] ; D. P. D'Cruz [Royaume-Uni] ; G. R. Hughes [Royaume-Uni] | Rheumatology. |
| 002F77 |
M. E. Murray [Royaume-Uni] ; T. C. Stokes [Royaume-Uni] | Endobronchial sarcoidosis presenting as severe upper airways narrowing with normal chest radiograph |
| 002F90 |
C. B. Bunker [Royaume-Uni] ; J. J. H. Gilkes [Royaume-Uni] | (52) Granulomatous cheilitis and Crohn's disease |
| 002F91 |
H. Baker [Royaume-Uni] ; I. M. Leigh [Royaume-Uni] ; C. M. Proby [Royaume-Uni] | (51) Sarcoidosis with severe dactylitis and acral calcinosis |
| 002F92 |
J. M. Mcgregor [Royaume-Uni] ; D. M. Macdonald [Royaume-Uni] | (44) Calcinosis cutis in polymyositis‐scleroderma (Pm‐ScI) overlap syndrome |
| 002F93 |
L. Ostlere [Royaume-Uni] ; D. Harris [Royaume-Uni] ; C. Buckley [Royaume-Uni] ; C. Black [Royaume-Uni] ; M. H. A. Rustin [Royaume-Uni] | (43) Atypical systemic sclerosis following exposure to polyvinyl chloride monomer |
| 002F94 |
P. C. Goldsmith [Royaume-Uni] ; M. Dowd [Royaume-Uni] | (42) Morphoea and mononeuritis multiplex |
| 002F95 |
S. C. Mayou [Royaume-Uni] ; D. D. Munro [Royaume-Uni] | (41) Discoid lupus erythematosus in vitiligo |
| 002F99 |
Catherine Hill [Royaume-Uni] ; Ellen Benhamou [Royaume-Uni] ; Françoise Doyon [Royaume-Uni] ; Stanc Freni [États-Unis] ; Devra Lee Davis [États-Unis] ; David Hoel [Royaume-Uni] ; John Fox [Royaume-Uni] ; Alan Lopez [Suisse] | Trends in cancer mortality |
| 003000 |
Ronaldg. Munger [États-Unis] ; Elizabetha. Booton [Royaume-Uni] | Thiamine and sudden death in sleep of South-East Asian refugees |
| 003033 |
Mittali Chatterjee [Royaume-Uni] ; Adrian L. Harris [Royaume-Uni] | Enhancement of adriamycin® cytotoxicity in a multidrug resistant Chinese hamster ovary (CHO) subline, CHO-Adrr, by toremifene and its modulation by alpha1 acid glycoprotein |
| 003052 |
Christian P. L. Lewis [Royaume-Uni] ; Gerald M. Cohen [Royaume-Uni] ; Lewis L. Smith [Royaume-Uni] | The identification and characterization of an uptake system for taurine into rat lung slices |
| 003055 |
E. O. Adeyemi [Royaume-Uni] ; V. S. Chadwick [Royaume-Uni] ; H. J. F. Hodgson [Royaume-Uni] | The Effect of Some Anti‐inflammatory Agents on Elastase Release From Neutrophils In‐vitro |
| 003063 |
G. F. Lucas [Royaume-Uni] ; P. A. Carrington [Royaume-Uni] | Results of the First International Granulocyte Serology Workshop |
| 003068 |
J. Wilson ; J. Varley ; R. Djukanovic ; R. Polosa ; O. Cromwell [Royaume-Uni] | News and commentary |
| 003071 |
H. A. Bird [Royaume-Uni] | Medical Treatment for Rheumatic Diseases |
| 003112 |
A. F. Flening [Royaume-Uni] | The presentation, management and prevention of crisis in sickle cell disease in Africa |
| 003114 |
Thomas Pullar [Royaume-Uni] | Sulphasalazine and related drugs in rheumatoid arthritis |
| 003128 |
G. Lloyd [Royaume-Uni] ; G. N Barber [Royaume-Uni] ; J. C. S Clegg [Royaume-Uni] ; P. Kelly [Irlande (pays)] | IDENTIFICATION OF LASSA FEVER VIRUS INFECTION WITH RECOMBINANT NUCLEOCAPSID PROTEIN ANTIGEN |
| 003130 |
P. M. Hallwood [Royaume-Uni] ; R. J. Horton [Royaume-Uni] ; K. M. O'Sullivan [Royaume-Uni] ; S. N. Parr [Royaume-Uni] | HALOFANTRINE AND PRURITUS |
| 003143 |
T. G. Palferman [Royaume-Uni] ; S. V. Beath [Royaume-Uni] | Acute Onset of Scleroderma following Subcapsular Orchidectomy for Carcinoma of Prostate |
| 003163 |
W. E. Gutteridge [Royaume-Uni] | Parasite vaccines versus anti-parasite drugs: rivals or running mates? |
| 003171 |
M. Cosgrove [Royaume-Uni] ; H. R. Jenkins [Royaume-Uni] ; P. H. Rowlandson [Royaume-Uni] ; O. P. Gray [Royaume-Uni] | Idiosyncratic reaction to nebulised ribavirin in an artifically ventilated neonate |
| 003181 |
Okezie I. Aruoma [Royaume-Uni] ; Barry Halliwell [Royaume-Uni] ; John Butler [Royaume-Uni] ; Brigid M. Hoey [Royaume-Uni] | Apparent inactivation of α1-antiroteinase by sulphur-containing radicals derived from penicillamine |
| 003203 |
J. A. Roberts [Royaume-Uni] ; A. Gunneberg [Royaume-Uni] ; J. A. Elliott [Royaume-Uni] ; N. C. Thomson [Royaume-Uni] | Hydroxychloroquine in steroid dependent asthma |
| 003204 |
Valeriom. Novelli [Qatar] ; Tohamia. El-Tohami [Qatar] ; Vincentm. Osundwa [Qatar] ; Frederick Ashong [Qatar] ; A. J. G. Barclay [Tanzanie] ; J. B. S. Coulter [Royaume-Uni] | FLOODS AND RESISTANT MALARIA |
| 003209 |
W. M Watkins [Kenya] ; J. D Lury [Kenya] ; D. Kariuki [Kenya] ; D. K Koech [Kenya] ; J. A Oloo [Kenya] ; M. Mosoba [Royaume-Uni] ; M. Mjomba [Royaume-Uni] ; H. M Gilles [Royaume-Uni] | EFFICACY OF MULTIPLE-DOSE HALOFANTRINE IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN CHILDREN IN KENYA |
| 003215 |
J. Wirima [Malawi] ; M. E. Molyneux [Royaume-Uni] ; C. Khoromana [Royaume-Uni] ; H. M. Gilles [Royaume-Uni] | CLINICAL TRIALS WITH HALOFANTRINE HYDROCHLORIDE IN MALAWI |
| 003217 |
S. Krishna [Royaume-Uni] ; T. M. E. Davis [Royaume-Uni] ; P. C. Y. Chan [Royaume-Uni] ; R. A. Wells [Royaume-Uni] ; K. J. H. Robson [Royaume-Uni] | CIPROFLOXACIN AND MALARIA |
| 003228 |
G. Bou-Gharios [Royaume-Uni] ; J. Moss [Royaume-Uni] ; I. Olsen [Royaume-Uni] ; T. Partridge [Royaume-Uni] | Ultrastructural localization of a lysosomal enzyme in resin-embedded lymphocytes |
| 003230 |
P. A. Winstanley [Royaume-Uni] ; G. Edwards [Royaume-Uni] ; C. G. Curtis ; M. L'E. Orme ; G. M. Powell ; A. M. Breckenridge | Tissue Distribution and Excretion of Amodiaquine in the Rat |
| 003237 |
Karen J. Quinn [Royaume-Uni] ; James M. Courtney [Royaume-Uni] | Silicones as biomaterials |
| 003240 |
A. C. Davidson [Royaume-Uni] ; C. Bateman [Royaume-Uni] ; C. Shovlin [Royaume-Uni] ; M. Marrinan [Royaume-Uni] ; G. H. Burton [Royaume-Uni] ; I. R. Cameron [Royaume-Uni] | Pulmonary toxicity of malaria prophylaxis. |
| 003246 |
N. H. Cox [Royaume-Uni] ; D. J. Gawkrodger [Royaume-Uni] | Nail dystrophy in chronic sarcoidosis |
| 003252 |
James R. Loudon [Royaume-Uni] | Hydroxychloroquine and postoperative thromboembolism after total hip replacement |
| 003253 |
C. B. Bunker [Royaume-Uni] ; Pauline M. Dowd [Royaume-Uni] | Giant cell arteritis and systemic lupus erythematosus |
| 003258 |
Julian L. Allen [États-Unis] ; Oommen P. Mathew [États-Unis] ; Peter Macfarlane [Royaume-Uni] ; David Heaf [Royaume-Uni] ; Hans Pasterkamp [Canada] ; Asher Tal [Israël] ; Micha Aviram [Israël] | Correspondence |
| 003261 |
Frederic R. Costa-Jussà [Royaume-Uni] ; Ana Guevara ; Gary A. Brook [Royaume-Uni] ; Leo W. Duchen [Royaume-Uni] ; Jean M. Jacobs [Royaume-Uni] | Changes in denervated skeletal muscle of amiodarone‐fed mice |
| 003264 |
C G Mackworth-Young [Royaume-Uni] ; J. David [Royaume-Uni] ; S H Morgan [Royaume-Uni] ; G R Hughes [Royaume-Uni] | A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus. |
| 003267 |
C. B. Bunker [Royaume-Uni] ; P. D. L. Maurice [Royaume-Uni] ; J. C. Sharp [Royaume-Uni] ; A. W. P. Du Vivier [Royaume-Uni] ; Pauline M. Dowd [Royaume-Uni] | (12) Scleroderma and polymyositis overlap syndrome associated with IgG lambda paraproteinaemia and cutaneous amyloid deposition |
| 003277 |
Alanj. Knox [Royaume-Uni] ; N. J. Shaw [Royaume-Uni] ; M. E. Chapman [Royaume-Uni] ; O. B. Eden [Royaume-Uni] | STEROIDS AND PNEUMOCYSTIS CARINII PNEUMONIA |
| 003278 |
Fraser Mutch [Royaume-Uni] | SAFETY OF LIVER BIOPSY |
| 003283 |
Jeremyk Nicholson [Royaume-Uni] ; Felicity Nicholson [Royaume-Uni] | PROTON SPECTROSCOPY OF PLASMA AND TESTING FOR MALIGNANCY |
| 003292 |
J. T. C. Kwan [Royaume-Uni] ; P. J. D. Foxall [Royaume-Uni] ; D. G. C. Davidson [Royaume-Uni] ; M. R. Bending [Royaume-Uni] ; A. J. Eisinger [Royaume-Uni] | INTERACTION OF CYCLOSPORIN AND ITRACONAZOLE |
| 003294 |
D. J. Mccance [Royaume-Uni] ; Patrick Walker [Royaume-Uni] ; Micheline Byrne ; D. Taylor-Robinson ; P. E. Munday ; J. R. W. Harris | HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER |
| 003295 |
Sornchai Looareesuwan [Thaïlande] ; Nicholasj. White [Thaïlande, Royaume-Uni] ; Danai Bunnag [Thaïlande] ; Sunee Chittamas [Thaïlande] ; Tranakchit Harinasuta [Thaïlande] | HIGH RATE OF PLASMODIUM VIVAX RELAPSE FOLLOWING TREATMENT OF FALCIPARUM MALARIA IN THAILAND |
| 003296 |
Gerdag. De Lange [Pays-Bas] ; Peterh. Van Eede [Pays-Bas] ; Jacobush. Ten Veen [Pays-Bas] ; Henkw. Reesink [Pays-Bas] ; P. Nico Lelie [Royaume-Uni] ; J. J. Lefrere [France] ; P. Rouger [France] ; J. Seger [France] ; F. Ferrer-Le-Coeur [France] ; D. Salmon [France] ; C. Salmon [France] | GROUP-SPECIFIC COMPONENT AND HIV INFECTION |
| 003297 |
B. Kreymann [Royaume-Uni] ; M. A. Ghatei [Royaume-Uni] ; G. Williams [Royaume-Uni] ; S. R. Bloom [Royaume-Uni] | GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN |
| 003301 |
Warren Schubert [Royaume-Uni] ; Gabriela Guzman-Stein [Royaume-Uni] ; Davidh. Ahrenholz [Royaume-Uni] ; Lynnd. Solem [Royaume-Uni] ; Brucel. Cunningham [Royaume-Uni] | FREE MUSCLE FLAP FOR TREATMENT OF IATROGENIC PNEUMOCEPHALUS |
| 003307 |
J. E. Ogbuokiri [Nigeria] ; M. J. Brueton [Royaume-Uni] ; B. M. Greenwood [Gambie] ; N. J. White [Thaïlande] ; K. D. Miller [Thaïlande] ; K. Marsh [Thaïlande] ; C. D. Berry [Thaïlande] ; R. C. Turner [Thaïlande] ; D. H. Williamson [Thaïlande] ; J. Brown [Thaïlande] | DOES CHLOROQUINE CAUSE HYPOGLYCAEMIA IN THE ABSENCE OF CLINICAL MALARIA? |
| 003308 |
V. V. Kakkar [Royaume-Uni] | Current recommendations in prevention of thrombosis in surgery |
| 003315 |
E. C. Huskisson [Royaume-Uni] | COMBINATION CHEMOTHERAPY IN RHEUMATOID ARTHRITIS |
| 003316 |
David Peterson [Royaume-Uni] | CHOLESTEROL, GHEE, AND ATHEROSCLEROSIS |
| 003318 |
John Pitts [Royaume-Uni] | BACTERIAL PHARYNGITIS |
| 003326 |
C. R. V. Tomson [Royaume-Uni] ; D. Veale [Royaume-Uni] ; K. Gould [Royaume-Uni] | ANTIBIOTIC POLICY AND INFECTIVE EXACERBATION OF OBSTRUCTIVE AIRWAYS DISEASE |
| 003384 |
Azim Lakhani [Royaume-Uni] ; John Charlton [Royaume-Uni] ; Maria Aristidou [Royaume-Uni] ; Martin Donaghy [Royaume-Uni] | MORTALITY FROM CAUSES AMENABLE TO HEALTH SERVICES INTERVENTION |
| 003394 |
A. Kay [Royaume-Uni] | EUROPEAN LEAGUE AGAINST RHEUMATISM STUDY OF ADVERSE REACTIONS TO D-PENICILLAMINE |
| 003397 |
Susanb. Roberts [Royaume-Uni] ; Judith Savage [Royaume-Uni] ; Alan Lucas [Royaume-Uni] | DOES LAMBSWOOL PROMOTE GROWTH IN PRETERM INFANTS? |
| 003412 |
M. D. Coleman [États-Unis] ; A. J. Thompson ; G. Edwards [Royaume-Uni] ; I. M. Braithwaite ; A. M. Breckenridge | The pharmacokinetics of pyrimethamine in the rat: effect of mefloquine |
| 003416 |
Gordon Cramb [Royaume-Uni] | Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems |
| 003425 |
P. T. Dawes [Royaume-Uni] ; D. H. Smith [Royaume-Uni] ; D. L. Scott [Royaume-Uni] | Massive eosinophilia in rheumatoid arthritis: Report of four cases |
| 003462 |
J. Weber [Royaume-Uni] | Sexually acquired parasitic infections in homosexual men |
| 003465 |
B. H. Raseroka [Royaume-Uni] ; W. E. Ormerod [Royaume-Uni] | SURAMIN/METRONIDAZOLE COMBINATION FOR AFRICAN SLEEPING SICKNESS |
| 003471 |
C. J. Ronalds [Royaume-Uni] ; A. E. Hardiman [Royaume-Uni] ; P. C. A. Grint [Royaume-Uni] ; H. O. Kangro [Royaume-Uni] | RUBELLA-SPECIFIC IgM DETERMINATION ON HEAT-TREATED SERA |
| 003480 |
R. M. Buchdahl [Royaume-Uni] ; P. Taylor [Royaume-Uni] ; J. O. Warner [Royaume-Uni] | NEBULISED RIBAVIRIN FOR ADENOVIRUS PNEUMONIA |
| 003492 |
Jacques Le Bras [France] ; Jean-Pierre Coulaud [France] ; Francois Bricaire [France] ; Michel Le Bras [France] ; René Roue [France] ; Bernard Grenier [Royaume-Uni] ; Martine Fournon [Royaume-Uni] | CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN THE CONGO |
| 003493 |
Beverleyj. Hunt [Royaume-Uni] ; U. M. Hegde [Royaume-Uni] ; Geraldine Martin [Royaume-Uni] ; I. L. Lampert [Royaume-Uni] ; Steven Myint [Royaume-Uni] ; Andrew Lowes [Royaume-Uni] | BACTERIAL ENDOCARDITIS WITH HICKMAN CATHETERS |
| 003501 |
Mikio Kato [Japon] ; Ryuji Kakehi [Japon] ; Gen-Ichiro Soma [Japon] ; Tetsuya Gatanaga [Royaume-Uni] ; Den'Ichi Mizuno [Royaume-Uni] | ANTI-TUMOUR THERAPY BY INDUCTION OF ENDOGENOUS TUMOUR NECROSIS FACTOR |
| 003504 |
M. D. Coleman [Royaume-Uni] ; G. W. Mihaly [Royaume-Uni] ; S. A. Ward [Royaume-Uni] ; G. Edwards [Royaume-Uni] ; R. E. Howells [Royaume-Uni] ; A. M. Breckenridge [Royaume-Uni] | The sustained release of pyrimethamine base or pyrimethamine pamoate from a biodegradable injectable depot preparation in mice |
| 003506 |
M. F. Heath [Royaume-Uni] ; W. Jacobson [Royaume-Uni] | The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant |
| 003507 |
Nobuyoshi Tanaka [Royaume-Uni, Japon] ; Mark Leaning [Royaume-Uni] ; Maureen Taylor [Royaume-Uni] ; John A. Summerfield [Royaume-Uni] | The effects of diabetes and insulin on glycoprotein metabolism by rat liver |
| 003516 |
M. D. Coleman ; G. W. Mihaly ; G. Edwards ; S. A. Ward ; R. E. Howells [Royaume-Uni] ; A. M. Breckenridge | Pyrimethamine pharmacokinetics and its tissue localization in mice: effect of dose size |
| 003555 |
R. A. Wilson [Royaume-Uni] ; P. S. Coulson [Royaume-Uni] | The effect of soft-wood sawdust bedding on the maturation of an infection of Schistosoma mansoni in mice exposed to cercariae via the tail or abdominal skin |
| 003561 |
Valerie Beral [Royaume-Uni] ; Eve Roman [Royaume-Uni] ; Linda Colwell [Royaume-Uni] | POOR REPRODUCTIVE OUTCOME IN INSULIN-DEPENDENT DIABETIC WOMEN ASSOCIATED WITH LATER DEVELOPMENT OF OTHER ENDOCRINE DISORDERS IN THE MOTHERS |
| 003563 |
John Rees [Royaume-Uni] ; Wyn Davies [Royaume-Uni] ; Paul Curry [Royaume-Uni] | MYOCARDIAL OXYGEN CONSUMPTION OR AVAILABILITY |
| 003565 |
Williame. Evans [Royaume-Uni] ; Clintonf. Stewart [Royaume-Uni] ; Chen-Hsin Chen [Royaume-Uni] ; Williamr. Crom [Royaume-Uni] ; W. Paul Bowman [Royaume-Uni] ; Minnie Abromowitch [Royaume-Uni] ; Josephv. Simone [Royaume-Uni] | METHOTREXATE SYSTEMIC CLEARANCE INFLUENCES PROBABILITY OF RELAPSE IN CHILDREN WITH STANDARD-RISK ACUTE LYMPHOCYTIC LEUKAEMIA |
| 003566 |
D. L. Cohen [Royaume-Uni] ; E. A. De Sousa [Royaume-Uni] ; J. S. Mindell [Royaume-Uni] | MALARIA IN BRENT: SUCCESSFUL TREATMENT IN THE COMMUNITY |
| 003567 |
M. J. Smeaton [Royaume-Uni] ; P. J. Slater [Royaume-Uni] ; P. Robson [Royaume-Uni] | MALARIA FROM A "COMMUTER" MOSQUITO |
| 003568 |
R. Million [Royaume-Uni] ; P. Poole [Royaume-Uni] ; J. H. Kellgren [Royaume-Uni] ; M. I. V. Jayson [Royaume-Uni] | LONG-TERM STUDY OF MANAGEMENT OF RHEUMATOID ARTHRITIS |
| 003572 |
J. E Smith [Royaume-Uni] ; J. F. G. M Meis [Pays-Bas] ; T. Ponnudurai [Pays-Bas] ; J. P Verhave [Pays-Bas] ; H. J Moshage [Pays-Bas] | IN-VITRO CULTURE OF EXOERYTHROCYTIC FORM OF PLASMODIUM FALCIPARUM IN ADULT HUMAN HEPATOCYTES |
| 003579 |
E. D. Acheson [Royaume-Uni] ; H. R. Barnes [Royaume-Uni] ; M. J. Gardner [Royaume-Uni] ; C. Osmond [Royaume-Uni] ; B. Pannett [Royaume-Uni] ; C. P. Taylor [Royaume-Uni] | COHORT STUDY OF FORMALDEHYDE PROCESS WORKERS |
| 003581 |
M. F. R. Martin [Royaume-Uni] ; F. Mckenna [Royaume-Uni] ; H. A. Bird [Royaume-Uni] ; K. E. Surrall [Royaume-Uni] ; J. S. Dixon [Royaume-Uni] ; V. Wright [Royaume-Uni] | CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS? |
| 003584 |
R. J. Davies [Royaume-Uni] ; C. J. Morley [Royaume-Uni] ; Daniel Stowens [États-Unis] ; Bruno Granati [Italie] ; Andrea Pettenazzo [Italie] ; Firminof. Rubaltelli [Italie] | ARTIFICIAL SURFACTANT |
| 003585 |
Harrisonc. Spencer [Royaume-Uni] ; A. James Oloo [Royaume-Uni] ; Williamw. Watkins [Royaume-Uni] ; Davidg. Sixsmith [Royaume-Uni] ; Fredc. Churchill [Royaume-Uni] ; Davyk. Koech [Royaume-Uni] | AMODIAQUINE MORE EFFECTIVE THAN CHLOROQUINE AGAINST PLASMODIUM FALCIPARUM MALARIA ON KENYA COAST |
| 003586 |
G. T. Lewith [Royaume-Uni] ; J. A. Jewell [Royaume-Uni] | ACUPUNCTURE |
| 003588 |
R. Glück [Suisse] ; A. Wegmann [Suisse] ; R. Germanier [Suisse] ; H. Keller [Royaume-Uni] ; M. W. Hess [Royaume-Uni] ; R. Kraus-Ruppert [Royaume-Uni] ; A. I. Wandeler [Royaume-Uni] | A NEW, HIGHLY IMMUNOGENIC DUCK EMBRYO RABIES VACCINE |
| 003615 |
F. R. Costa-Jussà [Royaume-Uni] ; B. Corrin [Royaume-Uni] ; J. M. Jacobs [Royaume-Uni] | Amiodarone lung toxicity: A human and experimental study |
| 003632 |
V. M. Novelli [Royaume-Uni] ; W. C. Marshall [Royaume-Uni] ; W. Hendrickse [Royaume-Uni] ; M. Levin [Royaume-Uni] ; J. Smallhorn [Royaume-Uni] ; A. Gailbraith [Royaume-Uni] ; G. Cherian [Royaume-Uni] ; E. J. Moynahan [Royaume-Uni] | KAWASAKI DISEASE IN LONDON |
| 003639 |
A. J. Howard [Royaume-Uni] ; M. Hughes [Royaume-Uni] ; H. Parry [Royaume-Uni] ; J. G. Roberts [Royaume-Uni] | DOG BITES AND DYSGONIC FERMENTING ORGANISMS |
| 003642 |
D. T. Hughes [Royaume-Uni] ; N. Cavanagh [Royaume-Uni] | CHROMOSOMAL STUDIES ON CHILDREN WITH PHOCOMELIA, EXPOSED TO DEBENDOX DURING EARLY PREGNANCY |
| 003686 |
David B. A. Hutchinson [Royaume-Uni] ; Jennifer A. Farquhar [Royaume-Uni] | Trimethoprim-Sulfamethoxazole in the Treatment of Malaria, Toxoplasmosis, and Pediculosis |
| 003687 |
D. Mitrovic [France] ; E. Mccall [France, Royaume-Uni] ; F. Dray [France] | The in vitro production of prostanoids by cultured bovine articular chondrocytes |
| 003692 |
J. J. F. Belch [Royaume-Uni] ; D. R. Meek [Royaume-Uni] ; G. D. O. Lowe [Royaume-Uni] ; A. F. Campbell [Royaume-Uni] ; A. B. Young [Royaume-Uni] ; C. D. Forbes [Royaume-Uni] ; C. R. M. Prentice [Royaume-Uni] | Subcutaneous ancrod in prevention of deep vein thrombosis after hip replacement surgery |
| 003694 |
Donald Whitfield [Royaume-Uni] | PRESUMPTIVE FATALITY DUE TO PYRIMETHAMINE-SULFADOXINE |
| 003695 |
Adrian J. Salter [Royaume-Uni] | Overview. Trimethoprim-Sulfamethoxazole: An Assessment of More Than 12 Years of Use |
| 003703 |
Maurice Super [Royaume-Uni] ; Elizabethm. Summers [Royaume-Uni] ; A. D. Milner [Royaume-Uni] ; H. Vyas [Royaume-Uni] | HAZARDS OF AMNIOCENTESIS |
| 003706 |
T. H. H. G. Kok [Royaume-Uni] ; L. S. Taitz [Royaume-Uni] ; M. J. Bennett [Royaume-Uni] ; D. W. Holt [Royaume-Uni] | DROWSINESS DUE TO CLEMASTINE TRANSMITTED IN BREAST MILK |
| 003708 |
Joan R. Rest [Royaume-Uni] | Cerebral malaria in inbred mice. I. A new model and its pathology |
| 003714 |
W. Peters [Royaume-Uni] | ANTIMALARIAL DRUG RESISTANCE: AN INCREASING PROBLEM |
| 003720 |
David Scott [Royaume-Uni] ; David Scott [Royaume-Uni] ; Paul Bacon [Royaume-Uni] | THERAPEUTIC PROGRESS—REVIEW VITREATMENT OF RHEUMATOID ARTHRITIS |
| 003731 |
A. M. Arnold [Royaume-Uni] ; J. M. A. Whitehouse [Royaume-Uni] | Interaction of VP16-213 with the DNA repair antagonist chloroquine |
| 003736 |
D. A. Isenberg [Royaume-Uni] ; A. Tookman [Royaume-Uni] ; A. G. White [Royaume-Uni] ; B. I. Hoffbrand [Royaume-Uni] ; J. Mowbray [Royaume-Uni] | Erosive rheumatoid arthritis co-existing with systemic lupus erythematosus. A report of a case, also showing atlanto-axial subluxation |
| 003763 |
Davida Fenton [Royaume-Uni] ; Johnd Wilkinson [Royaume-Uni] ; Johns English [Royaume-Uni] | PHOTOSENSITISATION TO BENOXAPROFEN NOT DUE TO ULTRAVIOLET A ALONE |
| 003772 |
John Dobbing [Royaume-Uni] | FALTERING GROWTH AND HUMAN MILK |
| 003774 |
Brian Darlow [Royaume-Uni] ; Helena Vrbova [Royaume-Uni] ; John Stace [Royaume-Uni] ; Peter Heywood [Royaume-Uni] ; Michael Alpers [Royaume-Uni] | DRUG RESISTANT STRAINS OF PLASMODIUM FALCIPARUM IN PAPUA NEW GUINEA |
| 003777 |
D. M. Jones [Royaume-Uni] ; J. D. Abbott [Royaume-Uni] ; Joan Eldridge [Royaume-Uni] ; Enidm. Sutcliffe [Royaume-Uni] | CAMPYLOBACTER SEROTYPING AND EPIDEMIOLOGY |
| 003778 |
K. G. Liddell [Royaume-Uni] ; S. B. Lucas [Kenya] ; H. Williams [Royaume-Uni] | Babesia divergens infections in the Mongolian gerbil: characteristics of a human strain |
| 003779 |
T. R. Littler [Royaume-Uni] | Anti-rheumatic drugs |
| 003782 |
S. J. Mesbahi [Royaume-Uni] ; Peter Davies [Royaume-Uni] | Unilateral pulmonary changes in the chest X-ray in sarcoidosis |
| 003791 |
Isobel P. Braidman [Royaume-Uni] ; K. Livingston [Royaume-Uni] ; I. W. Tomlinson [Royaume-Uni] ; M. I. V. Jayson [Royaume-Uni] ; M. K. Jasani [Royaume-Uni] | Effect of inflammatory arthritis on dexamethasone receptors in phagocytes—a possible role for plasma factors |
| 003809 |
M. N. Eakins [Royaume-Uni] ; R. W. Goulding [Royaume-Uni] ; S. Somaia [Royaume-Uni] | The distribution and metabolism in the rat of a short series of 4-amino-7-iodoquinolines labelled with radioiodine |
| 003810 |
Richard Knight [Royaume-Uni] | The chemotherapy of amoebiasis |
| 003815 |
G. K. Morris [Royaume-Uni] | PREVENTION OF VENOUS THROMBOEMBOLISM |
| 003825 |
Richard Feachem [Royaume-Uni] | BACTERIAL STANDARDS FOR DRINKING WATER QUALITY IN DEVELOPING COUNTRIES |
| 003836 |
A. P. Hall [Royaume-Uni] | Malaria |
| 003846 |
R. J. Jarrett [Royaume-Uni] ; A. E. Hugh [Royaume-Uni] ; Roryj. Farrell [Irlande (pays)] | WHY BLAME CHOLESTEROL? |
| 003864 |
B. Gylseth [Norvège] ; G. Mowé [Norvège] ; Alana. Watson [Royaume-Uni] | DIATOMS IN LUNG TISSUE |
| 003866 |
R. Bell [Royaume-Uni] ; D. S. Lawrence [Royaume-Uni] | Chronic pleurisy in systemic lupus erythematosus treated with pleurectomy |
| 003867 |
L. J. Bruce-Chwatt [Royaume-Uni] ; Wallace Peters [Royaume-Uni] | CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM IN AFRICA |
| 003875 |
Philip V. Harrison [Royaume-Uni] | THE ANNULAR ERYTHEMAS |
| 003883 |
A. K. Pain [Royaume-Uni] ; G. Donald [Royaume-Uni] ; W. Mckendrick [Royaume-Uni] | Indigenous amoebic liver abscess |
| 003943 |
A. P. Hall [Royaume-Uni] | The treatment of severe falciparum malaria |
| 003952 |
Alan Blackham [Royaume-Uni] ; Henryk Radziwonik [Royaume-Uni] | The effect of drugs in established rabbit monoarticular arthritis |
| 003964 |
M. N. Moore [Royaume-Uni] ; A. R. D. Stebbing [Royaume-Uni] | The quantitative cytochemical effects of three metal ions on a lysosomal hydrolase of a hydroid |
| 003982 |
G. Teeling-Smith [Royaume-Uni] | BRAND NAMES FOR DRUGS |
| 003996 |
A. J. Barson [Royaume-Uni] ; R. H. A. Campbell [Royaume-Uni] ; F. A. Langley [Royaume-Uni] ; R. D. G. Milner [Royaume-Uni] | Idiopathic arterial calcification of infancy without intimal proliferation |
| 003A02 |
D. Geraint James [Royaume-Uni] ; Edmund Neville [Royaume-Uni] ; L. S. Carstairs [Royaume-Uni] | Bone and joint sarcoidosis |
| 003A13 |
N. F. Johnson [Royaume-Uni] | Phagocytosis in the normal and ischaemic retinal pigment epithelium of the rabbit |
| 003A16 |
M. Sandler [Royaume-Uni] ; Lindae Fellows [Royaume-Uni] ; D. B Calne [Royaume-Uni] ; L. J Findley [Royaume-Uni] | OXPRENOLOL AND LEVODOPA IN PARKINSONIAN PATIENTS |
| 003A23 |
Dan Mercola [Royaume-Uni] ; Belinda Bullard [Royaume-Uni] ; Joanna Priest [Royaume-Uni] | Crystallisation of troponin-C |
| 003A25 |
Betty Mosedale [Royaume-Uni] ; M. A Smith [Royaume-Uni] | CORYNEBACTERIUM PARVUM AND ANÆSTHETICS |
| 003A28 |
H. Alistair Reid [Royaume-Uni] | ADJUVANT TREATMENT OF SEVERE FALCIPARUM MALARIA, INTRAVASCULAR COAGULATION, AND HEPARIN |
| 003A30 |
Alan Blackham [Royaume-Uni] ; Henryk Radziwonik [Royaume-Uni] ; Ian H. Shaw [Royaume-Uni] | The Arthus reaction in guinea-pig knee joints. A test for anti-inflammatory drugs |
| 003A51 |
J. N. P. Davies [États-Unis] ; Peter Barnes ; R. B. Mcgucken [Royaume-Uni] | ANTIMALARIAL DRUGS AND BURKITT'S LYMPHOMA |
| 003A69 |
David Cade [Royaume-Uni] ; G. D. Webster | Amoebic perforation of the intestine in children |
| 003A73 |
N. R. Rowell [Royaume-Uni] | A painful bleeding syndrome associated with increased fibrinolytic activity |
| 003B06 |
G. G. Crane [Guinée, Royaume-Uni] ; D. S. Pryor [Guinée, Royaume-Uni] ; J. Vivian Wells [Guinée, Royaume-Uni] | Tropical splenomegaly syndrome in New Guinea II. Long term results of splenectomy |
| 003B09 |
M. G. Taylor [Royaume-Uni] ; G. S. Nelson [Royaume-Uni] | Response of Schistosoma haematobium infection to chemotherapy |
| 003B14 |
Chukuedu Nwokolo [Royaume-Uni] | OUTBREAK OF PARAGONIMIASIS IN EASTERN NIGERIA |
| 003B21 |
H. A. Reid [Royaume-Uni] ; P. Sucharit [Royaume-Uni] | ANCROD, HEPARIN, AND ∈-AMINOCAPROIC ACID IN SIMIAN KNOWLESI MALARIA |
| 003B52 |
Neil A. Croll [Royaume-Uni] ; R. Killick-Kendrick [Royaume-Uni] | Epidemiological significance of Strongyloides in sputum |
| 003B54 |
J. Trevor Hughes [Royaume-Uni] ; Margaret Esiri [Royaume-Uni] ; J. M. Oxbury [Royaume-Uni] ; C. W. M. Whitty [Royaume-Uni] | Chloroquine Myopathy |
| 003B91 |
Margaret Turner-Warwick [Royaume-Uni] | Host and antigen in industrial asthma |
| 003B94 |
D. C. F. Muir [Royaume-Uni] | Deposition and retention of dust in the lungs |
| 003C05 |
Ann E. Robinson [Royaume-Uni] ; Arnold I. Coffer [Royaume-Uni] ; Francis E. Camps [Royaume-Uni] | The distribution of chloroquine in man after fatal poisoning |
| 003C32 |
J. R Kalden [Royaume-Uni] ; W. J Irvine [Royaume-Uni] | EXPERIMENTAL MYASTHENIA GRAVIS |
| 003C33 |
N. L. Browse [Royaume-Uni] ; J. H. Hall [Royaume-Uni] | EFFECT OF DIPYRIDAMOLE ON THE INCIDENCE OF CLINICALLY DETECTABLE DEEP-VEIN THROMBOSIS |
| 003C67 |
R. J. Kellett [Royaume-Uni] ; G. O. Cowan [Royaume-Uni] ; E. S. Parry [Royaume-Uni] | CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM MALARIA IN THE UNITED KINGDOM |
| 003C93 |
H. A. Reid [Royaume-Uni] ; H. J. Goldsmith [Royaume-Uni] ; F. K. Wright [Royaume-Uni] | PERITONEAL DIALYSIS IN ACUTE RENAL FAILURE FOLLOWING MALARIA |
| 003C95 |
H. A. K. Rowland [Royaume-Uni] | Amoebiasis in freetown, Sierra Leone |
| 003C99 |
M. Dawson [Royaume-Uni] ; W. F. Dryden [Royaume-Uni] | Tissue culture in the study of the effects of drugs |
| 003D35 |
I. F. Skidmore [Royaume-Uni] ; M. W. Whitehouse | Concerning the regulation of some diverse biochemical reactions underlying the inflammatory response by salicylic acid, phenylbutazone and other acidic antirheumatic drugs |
| 003D42 |
H. L. F. Currey [Royaume-Uni] ; J. N. Blau [Royaume-Uni] | THE CARPAL-TUNNEL SYNDROME |
| 003D50 |
Frank Hawking [Royaume-Uni] | Advances in filariasis especially concerning periodicity of microfilariae |
| 003D51 |
Walfordj. Harrison [Royaume-Uni] | AUTOANTIBODIES IN ULCERATIVE COLITIS |
| 003D60 |
R. A. Dalley [Royaume-Uni] ; D. Hainsworth [Royaume-Uni] | Fatal Plaquenil Poisoning |
| 003D85 |
Gerald Weissmann [Royaume-Uni] | LYSOSOMES, AUTOIMMUNE PHENOMENA, AND DISEASES OF CONNECTIVE TISSUE |
| 003D86 |
R. Rewell [Royaume-Uni] ; W. L. Whitehouse [Royaume-Uni] | HYPOFIBRINOGENÆAMIA IN PREGNANCY |
| 003E13 |
Pauline Monro [Royaume-Uni] | TREATMENT OF MYASTHENIA GRAVIS |
| 003E15 |
F. E Kingston [Royaume-Uni] | THE DEMAND FOR PSYCHIATRIC BEDS |
| 003E20 |
A. C. Dornhorst [Royaume-Uni] ; B. F. Robinson [Royaume-Uni] | CHLOROQUINE PSYCHOSIS? |
| 003E21 |
D. A. H. Yates [Royaume-Uni] | CAVITATION OF A RHEUMATOID LUNG NODULE |
| 003E25 |
H. O. J. Collier [Royaume-Uni] | THE ACTION AND ANTAGONISM OF KININS ON BRONCHIOLES |
| 003E28 |
D. Davies [Royaume-Uni] | Sarcoidosis treated with chloroquine |
| 003E84 |
H. Fuld [Royaume-Uni] | SARCOIDOSIS TREATED WITH CHLOROQUINE |
| 003E86 |
H. M. Gilles [Royaume-Uni, Nigeria] ; A. C. Ikeme [Royaume-Uni, Nigeria] | HÆMOGLOBINURIA AMONG ADULT NIGERIANS DUE TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY WITH DRUG SENSITIVITY |
| 003E87 |
A. H. T. Robb-Smith [Royaume-Uni] | ATHEROSCLEROSIS AND CORONARY HEART-DISEASE |
| 003E88 |
Alick Isaacs [Royaume-Uni] ; Samuel Baron [Royaume-Uni] | ANTIVIRAL ACTION OF INTERFERON IN EMBRYONIC CELLS |
| 003E89 |
W. G. Spector [Royaume-Uni] ; D. A. Willoughby [Royaume-Uni] | The suppression by anti‐esterases of increased capillary permeability in acute inflammation |
| 003F23 |
Niilo K Rki [Royaume-Uni] ; Georgep. Burn [Royaume-Uni] ; J. H. Burn [Royaume-Uni] | THE EFFECT OF QUINIDINE ON POTASSIUM FLUX |
| 003F25 |
H. Gaylis [Royaume-Uni] | Thromboangiitis Obliterans in a Female |
| 003F26 |
C. D. Calnan [Royaume-Uni] | LYMPHOCYTIC INFILTRATION OF THE SKIN (JESSNER). |
| 003F33 |
H. C. Trowell [Royaume-Uni] ; J. M. Vaizey [Royaume-Uni] | TREATMENT OF BLACKWATER FEVER WITH PREDNISONE |
| 003F34 |
Joseph Luder [Royaume-Uni] | THE DIARRHOEA AND VOMITING SYNDROME IN AFRICAN CHILDREN IN UGANDA |
| 003F47 |
E. A. Pask [Royaume-Uni] | ARTIFICIAL RESPIRATION BY INTERMITTENT POSITIVE PRESSURE |
| 003F72 |
D. G. Davey [Royaume-Uni] | CHEMOTHERAPY OF MALARIA |
| 004018 |
Katherine G. Zyner [Royaume-Uni] ; Darcie S. Mulhearn [Royaume-Uni] ; Santosh Adhikari [Royaume-Uni] ; Sergio Martínez Cuesta [Royaume-Uni] ; Marco Di Antonio [Royaume-Uni] ; Nicolas Erard [Royaume-Uni] ; Gregory J. Hannon [Royaume-Uni] ; David Tannahill [Royaume-Uni] ; Shankar Balasubramanian [Royaume-Uni] | Genetic interactions of G-quadruplexes in humans |
